Glenn M. Chertow

Publications

• Menopausal symptoms in women with chronic kidney disease.
  Cheung, K. L., Stefanick, M. L., Allison, M. A., LeBlanc, E. S., Vitolins, M. Z., & Kurella Tamura, M. (2015). Menopausal symptoms in women with chronic kidney disease. Menopause (New York, N.Y.), 22(9), 1006-1011.
• Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial
  Rocco, M. V., Daugirdas, J. T., Greene, T., Lockridge, R. S., Chan, C., & Kliger, A. S. (2015). Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial. AMERICAN JOURNAL OF KIDNEY DISEASES, 66(3), 459-468.
• Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial.
  Rocco, M. V., Daugirdas, J. T., Greene, T., Lockridge, R. S., Chan, C., & Kliger, A. S. (2015). Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial. American journal of kidney diseases , 66(3), 459-468.
• Risk prediction models for contrast induced nephropathy: systematic review Silver, S. A., Shah, P. M., Chertow, G. M., Harel, S., Wald, R., & Harel, Z. (2015). Risk prediction models for contrast induced nephropathy: systematic review. BMJ-BRITISH MEDICAL JOURNAL, 351.
  
• Provider Visits and Early Vascular Access Placement in Maintenance Hemodialysis Erickson, K. F., Mell, M., Winkelmayer, W. C., Chertow, G. M., & Bhattacharya, J. (2015). Provider Visits and Early Vascular Access Placement in Maintenance Hemodialysis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 26(8), 1990-1997.
  
• Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Moe, S. M., Chertow, G. M., Parfrey, P. S., Kubo, Y., Block, G. A., & Floege, J. (2015). Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. CIRCULATION, 132(1), 27-39.
  
• Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. Moe, S. M., Chertow, G. M., Parfrey, P. S., Kubo, Y., Block, G. A., & Floege, J. (2015). Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. Circulation, 132(1), 27-39.
  
• Prevalence of chronic kidney disease in two major Indian cities and projections for associated cardiovascular disease Anand, S., Shivashankar, R., Ali, M. K., Kondal, D., Binukumar, B., & Prabhakaran, D. (2015). Prevalence of chronic kidney disease in two major Indian cities and projections for associated cardiovascular disease. KIDNEY INTERNATIONAL, 88(1), 178-185.
  
• Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis Kaysen, G. A., Johansen, K. L., Chertow, G. M., Dalrymple, L. S., Kornak, J., & Fiehn, O. (2015). Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis. JOURNAL OF RENAL NUTRITION, 25(4), 351-356.
  
• Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis. Kaysen, G. A., Johansen, K. L., Chertow, G. M., Dalrymple, L. S., Kornak, J., & Fiehn, O. (2015). Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis. Journal of renal nutrition , 25(4), 351-356.
  
• Longer-term Outcomes of Darbepoetin Alfa Versus Epoetin Alfa in Patients With ESRD Initiating Hemodialysis: A Quasi-experimental Cohort Study Winkelmayer, W. C., Chang, T. I., Mitani, A. A., Wilhelm-Leen, E. R., Ding, V., & Goldstein, B. A. (2015). Longer-term Outcomes of Darbepoetin Alfa Versus Epoetin Alfa in Patients With ESRD Initiating Hemodialysis: A Quasi-experimental Cohort Study. AMERICAN JOURNAL OF KIDNEY DISEASES, 66(1), 106-113.
  
• Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial. Kubo, Y., Sterling, L. R., Parfrey, P. S., Gill, K., Mahaffey, K. W., & Chertow, G. M. (2015). Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial. Pharmaceutical statistics, 14(4), 368-?.
  
• Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial Moe, S. M., Abdalla, S., Chertow, G. M., Parfrey, P. S., Block, G. A., & Drueeke, T. B. (2015). Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 26(6), 1466-1475.
  
• Evaluating Risk of ESRD in the Urban Poor Maziarz, M., Black, R. A., Fong, C. T., Himmelfarb, J., Chertow, G. M., & Hall, Y. N. (2015). Evaluating Risk of ESRD in the Urban Poor. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 26(6), 1434-1442.
  
• Red blood cell transfusion, hyperkalemia, and heart failure in advanced chronic kidney disease Gill, K., Fink, J. C., Gilbertson, D. T., Monda, K. L., Muntner, P., & Bradbury, B. D. (2015). Red blood cell transfusion, hyperkalemia, and heart failure in advanced chronic kidney disease. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 24(6), 654-662.
  
• The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. Parfrey, P. S., Drüeke, T. B., Block, G. A., Correa-Rotter, R., Floege, J., & Chertow, G. M. (2015). The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. Clinical journal of the American Society of Nephrology , 10(5), 791-799.
  
• Outcomes of Infection-Related Hospitalization in Medicare Beneficiaries Receiving In-Center Hemodialysis Dalrymple, L. S., Mu, Y., Romano, P. S., Nguyen, D. V., Chertow, G. M., & Johansen, K. L. (2015). Outcomes of Infection-Related Hospitalization in Medicare Beneficiaries Receiving In-Center Hemodialysis. AMERICAN JOURNAL OF KIDNEY DISEASES, 65(5), 754-762.
  
• Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial Kubo, Y., Sterling, L. R., Parfrey, P. S., Gill, K., Mahaffey, K. W., & Chertow, G. M. (2015). Assessing the treatment effect in a randomized controlled trial with extensive non-adherence: the EVOLVE trial. PHARMACEUTICAL STATISTICS, 14(3), 242-251.
  
• The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Parfrey, P. S., Drueeke, T. B., Block, G. A., Correa-Rotter, R., Floege, J., & Chertow, G. M. (2015). The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 10(5), 791-799.
  
• The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial Floege, J., Kubo, Y., Floege, A., Chertow, G. M., & Parfrey, P. S. (2015). The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 10(5), 800-807.
  
• A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5 Block, G. A., Fishbane, S., Rodriguez, M., Smits, G., Shemesh, S., & Chertow, G. M. (2015). A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5. AMERICAN JOURNAL OF KIDNEY DISEASES, 65(5), 728-736.
  
• Time-Updated Systolic Blood Pressure and the Progression of Chronic Kidney Disease A Cohort Study Anderson, A. H., Yang, W., Townsend, R. R., Pan, Q., Chertow, G. M., & Feldman, H. I. (2015). Time-Updated Systolic Blood Pressure and the Progression of Chronic Kidney Disease A Cohort Study. ANNALS OF INTERNAL MEDICINE, 162(4), 258-?.
  
• Provider Visit Frequency and Vascular Access Interventions in Hemodialysis Erickson, K. F., Mell, M. W., Winkelmayer, W. C., Chertow, G. M., & Bhattacharya, J. (2015). Provider Visit Frequency and Vascular Access Interventions in Hemodialysis. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 10(2), 269-277.
  
• Design of a Phase 2 Clinical Trial of an ASK1 Inhibitor, GS-4997, in Patients with Diabetic Kidney Disease Lin, J. H., Zhang, J. J., Lin, S.-L., & Chertow, G. M. (2015). Design of a Phase 2 Clinical Trial of an ASK1 Inhibitor, GS-4997, in Patients with Diabetic Kidney Disease. NEPHRON, 129(1), 29-33.
  
• Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial Wheeler, D. C., London, G. M., Parfrey, P. S., Block, G. A., Correa-Rotter, R., & Herzog, C. A. (2015). Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 4(1).
  
• Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial Wheeler, D. C., London, G. M., Parfrey, P. S., Block, G. A., Correa-Rotter, R., & Herzog, C. A. (2014). Effects of Cinacalcet on Atherosclerotic and Nonatherosclerotic Cardiovascular Events in Patients Receiving Hemodialysis: The EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) Trial. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 3(6).
  
• Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl Chin, M. P., Wrolstad, D., Bakris, G. L., Chertow, G. M., de Zeeuw, D., & Meyer, C. J. (2014). Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl. JOURNAL OF CARDIAC FAILURE, 20(12), 953-958.
  
• Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial. Wheeler, D. C., London, G. M., Parfrey, P. S., Block, G. A., Correa-Rotter, R., & Herzog, C. A. (2014). Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial. Journal of the American Heart Association, 3(6).
  
• Comparison of Self-report-Based and Physical Performance-Based Frailty Definitions Among Patients Receiving Maintenance Hemodialysis Johansen, K. L., Dalrymple, L. S., Delgado, C., Kaysen, G. A., Kornak, J., & Chertow, G. M. (2014). Comparison of Self-report-Based and Physical Performance-Based Frailty Definitions Among Patients Receiving Maintenance Hemodialysis. AMERICAN JOURNAL OF KIDNEY DISEASES, 64(4), 600-607.
  
• Thienopyridine use after coronary stenting in low income patients enrolled in medicare part D receiving maintenance dialysis. Chang, T. I., Montez-Rath, M. E., Shen, J. I., Solomon, M. D., Chertow, G. M., & Winkelmayer, W. C. (2014). Thienopyridine use after coronary stenting in low income patients enrolled in medicare part D receiving maintenance dialysis. Journal of the American Heart Association, 3(5).
  
• Comparison of self-report-based and physical performance-based frailty definitions among patients receiving maintenance hemodialysis. Johansen, K. L., Dalrymple, L. S., Delgado, C., Kaysen, G. A., Kornak, J., & Chertow, G. M. (2014). Comparison of self-report-based and physical performance-based frailty definitions among patients receiving maintenance hemodialysis. American journal of kidney diseases , 64(4), 600-607.
  
• Physician Visits and 30-Day Hospital Readmissions in Patients Receiving Hemodialysis Erickson, K. F., Winkelmayer, W. C., Chertow, G. M., & Bhattacharya, J. (2014). Physician Visits and 30-Day Hospital Readmissions in Patients Receiving Hemodialysis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 25(9), 2079-2087.
  
• Homelessness and Risk of End-stage Renal Disease Maziarz, M., Chertow, G. M., Himmeffarb, J., & Hall, Y. N. (2014). Homelessness and Risk of End-stage Renal Disease. JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 25(3), 1231-1244.
  
• Prognostic Stratification in Older Adults Commencing Dialysis Cheung, K. L., Montez-Rath, M. E., Chertow, G. M., Winkelmayer, W. C., Periyakoil, V. S., & Tamura, M. K. (2014). Prognostic Stratification in Older Adults Commencing Dialysis. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 69(8), 1033-1039.
  
• Anticoagulation, delivered dose and outcomes in CRRT: The program to improve care in acute renal disease (PICARD) Claure-Del Granado, R., Macedo, E., Soroko, S., Kim, Y., Chertow, G. M., & Mehta, R. L. (2014). Anticoagulation, delivered dose and outcomes in CRRT: The program to improve care in acute renal disease (PICARD). HEMODIALYSIS INTERNATIONAL, 18(3), 641-649.
  
• Characteristics and performance of minority-serving dialysis facilities. Hall, Y. N., Xu, P., Chertow, G. M., & Himmelfarb, J. (2014). Characteristics and performance of minority-serving dialysis facilities. Health services research, 49(3), 971-991.
  
• Characteristics and Performance of Minority-Serving Dialysis Facilities Hall, Y. N., Xu, P., Chertow, G. M., & Himmelfarb, J. (2014). Characteristics and Performance of Minority-Serving Dialysis Facilities. HEALTH SERVICES RESEARCH, 49(3), 971-991.
  
• Effects of Frequent Hemodialysis on Perceived Caregiver Burden in the Frequent Hemodialysis Network Trials Suri, R. S., Larive, B., Hall, Y., Kimmel, P. L., Kliger, A. S., & Chertow, G. M. (2014). Effects of Frequent Hemodialysis on Perceived Caregiver Burden in the Frequent Hemodialysis Network Trials. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 9(5), 936-942.
  
• Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy era. Conti, S. L., Thomas, I.-C., Hagedorn, J. C., Chung, B. I., Chertow, G. M., & Leppert, J. T. (2014). Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy era. International journal of cancer. Journal international du cancer, 134(9), 2245-2252.
  
• Estimation of 24-hour urine phosphate excretion from spot urine collection: development of a predictive equation. Robinson-Cohen, C., Ix, J. H., Smits, G., Persky, M., Chertow, G. M., & Kestenbaum, B. R. (2014). Estimation of 24-hour urine phosphate excretion from spot urine collection: development of a predictive equation. Journal of renal nutrition , 24(3), 194-199.
  
• Calibration of the Brief Food Frequency Questionnaire Among Patients on Dialysis Delgado, C., Ward, P., Chertow, G. M., Storer, L., Dalrymple, L., & Johansen, K. L. (2014). Calibration of the Brief Food Frequency Questionnaire Among Patients on Dialysis. JOURNAL OF RENAL NUTRITION, 24(3), 151-U30.
  
• KRAS mutation confers resistance to antibody-dependent cellular cytotoxicity of cetuximab against human colorectal cancer cells Conti, S. L., Thomas, I.-C., Hagedorn, J. C., Chung, B. I., Chertow, G. M., & Leppert, J. T. (2014). KRAS mutation confers resistance to antibody-dependent cellular cytotoxicity of cetuximab against human colorectal cancer cells. INTERNATIONAL JOURNAL OF CANCER, 134(9), 2245-2252.
  
• Trends in Anemia Care in Older Patients Approaching End-Stage Renal Disease in the United States (1995-2010) Winkelmayer, W. C., Mitani, A. A., Goldstein, B. A., Brookhart, M. A., & Chertow, G. M. (2014). Trends in Anemia Care in Older Patients Approaching End-Stage Renal Disease in the United States (1995-2010). JAMA INTERNAL MEDICINE, 174(5), 699-707.
  
• Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease. Chertow, G. M., & de Zeeuw, D. (2014). Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease. New England journal of medicine, 370(18), 1768-?.
  
• Calibration of the brief food frequency questionnaire among patients on dialysis. Delgado, C., Ward, P., Chertow, G. M., Storer, L., Dalrymple, L., & Johansen, K. L. (2014). Calibration of the brief food frequency questionnaire among patients on dialysis. Journal of renal nutrition , 24(3), 151-156 e1.
  
• Estimation of 24-Hour Urine Phosphate Excretion From Spot Urine Collection: Development of a Predictive Equation Robinson-Cohen, C., Ix, J. H., Smits, G., Persky, M., Chertow, G. M., & Kestenbaum, B. R. (2014). Estimation of 24-Hour Urine Phosphate Excretion From Spot Urine Collection: Development of a Predictive Equation. JOURNAL OF RENAL NUTRITION, 24(3), 194-199.
  
• Reply. Leppert, J. T., Hanley, J., Wagner, T. H., Chung, B. I., Brooks, J. D., & Saigal, C. S. (2014). Reply. Urology, 83(4), 779-780.
  
• Utilization of Renal Mass Biopsy in Patients With Renal Cell Carcinoma Leppert, J. T., Hanley, J., Wagner, T. H., Chung, B. I., Srinivas, S., & Saigal, C. S. (2014). Utilization of Renal Mass Biopsy in Patients With Renal Cell Carcinoma. UROLOGY, 83(4), 774-779.
  
• Temporal Trends in the Incidence, Treatment and Outcomes of Hip Fracture After First Kidney Transplantation in the United States Nair, S. S., Lenihan, C. R., Montez-Rath, M. E., Lowenberg, D. W., Chertow, G. M., & Winkelmayer, W. C. (2014). Temporal Trends in the Incidence, Treatment and Outcomes of Hip Fracture After First Kidney Transplantation in the United States. AMERICAN JOURNAL OF TRANSPLANTATION, 14(4), 943-951.
  
• High prevalence of chronic kidney disease in a community survey of urban Bangladeshis: a cross-sectional study Anand, S., Khanam, M. A., Saquib, J., Saquib, N., Ahmed, T., & Chertow, G. M. (2014). High prevalence of chronic kidney disease in a community survey of urban Bangladeshis: a cross-sectional study. GLOBALIZATION AND HEALTH, 10.
  
• Association between body composition and frailty among prevalent hemodialysis patients: a US Renal Data System special study. Johansen, K. L., Dalrymple, L. S., Delgado, C., Kaysen, G. A., Kornak, J., & Chertow, G. M. (2014). Association between body composition and frailty among prevalent hemodialysis patients: a US Renal Data System special study. Journal of the American Society of Nephrology , 25(2), 381-389.
  
• Changes in serum inflammatory markers are associated with changes in apolipoprotein A1 but not B after the initiation of dialysis. Kaysen, G. A., Dalrymple, L. S., Grimes, B., Chertow, G. M., Kornak, J., & Johansen, K. L. (2014). Changes in serum inflammatory markers are associated with changes in apolipoprotein A1 but not B after the initiation of dialysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 29(2), 430-437.
  
• Changes in serum inflammatory markers are associated with changes in apolipoprotein A1 but not B after the initiation of dialysis Kaysen, G. A., Dalrymple, L. S., Grimes, B., Chertow, G. M., Kornak, J., & Johansen, K. L. (2014). Changes in serum inflammatory markers are associated with changes in apolipoprotein A1 but not B after the initiation of dialysis. NEPHROLOGY DIALYSIS TRANSPLANTATION, 29(2), 430-437.
  
• Association between Body Composition and Frailty among Prevalent Hemodialysis Patients: A US Renal Data System Special Study Johansen, K. L., Dalrymple, L. S., Delgado, C., Kaysen, G. A., Kornak, J., & Chertow, G. M. (2014). Association between Body Composition and Frailty among Prevalent Hemodialysis Patients: A US Renal Data System Special Study. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 25(2), 381-389.
  
• Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Erickson, K. F., Chertow, G. M., & Goldhaber-Fiebert, J. D. (2014). Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Annals of internal medicine, 160(2), 143-?.
  
• Comparison of Hospitalization Rates among For-Profit and Nonprofit Dialysis Facilities Dalrymple, L. S., Johansen, K. L., Romano, P. S., Chertow, G. M., Mu, Y., & Nguyen, D. V. (2014). Comparison of Hospitalization Rates among For-Profit and Nonprofit Dialysis Facilities. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 9(1), 73-81.
  
• Visit-to-visit systolic blood pressure variability and outcomes in hemodialysis Chang, T. I., Flythe, J. E., Brunelli, S. M., Muntner, P., Greene, T., & Chertow, G. M. (2014). Visit-to-visit systolic blood pressure variability and outcomes in hemodialysis. JOURNAL OF HUMAN HYPERTENSION, 28(1), 18-24.
  
• Phase Angle, Frailty and Mortality in Older Adults Wilhelm-Leen, E. R., Hall, Y. N., Horwitz, R. I., & Chertow, G. M. (2014). Phase Angle, Frailty and Mortality in Older Adults. JOURNAL OF GENERAL INTERNAL MEDICINE, 29(1), 147-154.
  
• High prevalence of chronic kidney disease in a community survey of urban Bangladeshis: a cross-sectional study. Anand, S., Khanam, M. A., Saquib, J., Saquib, N., Ahmed, T., & Chertow, G. M. (2014). High prevalence of chronic kidney disease in a community survey of urban Bangladeshis: a cross-sectional study. Globalization and health, 10, 9-?.
  
• Comparison of hospitalization rates among for-profit and nonprofit dialysis facilities. Dalrymple, L. S., Johansen, K. L., Romano, P. S., Chertow, G. M., Mu, Y., & Nguyen, D. V. (2014). Comparison of hospitalization rates among for-profit and nonprofit dialysis facilities. Clinical journal of the American Society of Nephrology , 9(1), 73-81.
  
• Effects of daily hemodialysis on heart rate variability: results from the Frequent Hemodialysis Network (FHN) Daily Trial Chan, C. T., Chertow, G. M., Daugirdas, J. T., Greene, T. H., Kotanko, P., & Stokes, J. B. (2014). Effects of daily hemodialysis on heart rate variability: results from the Frequent Hemodialysis Network (FHN) Daily Trial. NEPHROLOGY DIALYSIS TRANSPLANTATION, 29(1), 168-178.
  
• Diabetic Severity and Risk of Kidney Stone Disease Weinberg, A. E., Patel, C. J., Chertow, G. M., & Leppert, J. T. (2014). Diabetic Severity and Risk of Kidney Stone Disease. EUROPEAN UROLOGY, 65(1), 242-247.
  
• Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease de Zeeuw, D., Akizawa, T., Audhya, P., Bakris, G. L., Chin, M., & Chertow, G. M. (2013). Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease. NEW ENGLAND JOURNAL OF MEDICINE, 369(26), 2492-2503.
  
• Effects of Frequent Hemodialysis on Ventricular Volumes and Left Ventricular Remodeling Chan, C. T., Greene, T., Chertow, G. M., Kliger, A. S., Stokes, J. B., & Rajagopalan, S. (2013). Effects of Frequent Hemodialysis on Ventricular Volumes and Left Ventricular Remodeling. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 8(12), 2106-2116.
  
• Systematic evaluation of environmental and behavioural factors associated with all-cause mortality in the United States National Health and Nutrition Examination Survey Patel, C. J., Rehkopf, D. H., Leppert, J. T., Bortz, W. M., Cullen, M. R., & Ioannidis, J. Pa. (2013). Systematic evaluation of environmental and behavioural factors associated with all-cause mortality in the United States National Health and Nutrition Examination Survey. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 42(6), 1795-1810.
  
• Diabetes Severity, Metabolic Syndrome, and the Risk of Erectile Dysfunction Weinberg, A. E., Eisenberg, M., Patel, C. J., Chertow, G. M., & Leppert, J. T. (2013). Diabetes Severity, Metabolic Syndrome, and the Risk of Erectile Dysfunction. JOURNAL OF SEXUAL MEDICINE, 10(12), 3102-3109.
  
• The Clinical Course of Treated Hyperparathyroidism Among Patients Receiving Hemodialysis and the Effect of Cinacalcet: The EVOLVE Trial Parfrey, P. S., Chertow, G. M., Block, G. A., Correa-Rotter, R., Drueeke, T. B., & Goodman, W. G. (2013). The Clinical Course of Treated Hyperparathyroidism Among Patients Receiving Hemodialysis and the Effect of Cinacalcet: The EVOLVE Trial. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 98(12), 4834-4844.
  
• Vitamin D deficiency and mortality in patients receiving dialysis: the Comprehensive Dialysis Study. Anand, S., Chertow, G. M., Johansen, K. L., Grimes, B., Dalrymple, L. S., & Kurella Tamura, M. (2013). Vitamin D deficiency and mortality in patients receiving dialysis: the Comprehensive Dialysis Study. Journal of renal nutrition , 23(6), 422-427.
  
• Sensitization from transfusion in patients awaiting primary kidney transplant Yabu, J. M., Anderson, M. W., Kim, D., Bradbury, B. D., Lou, C. D., & Tyan, D. B. (2013). Sensitization from transfusion in patients awaiting primary kidney transplant. NEPHROLOGY DIALYSIS TRANSPLANTATION, 28(11), 2908-2918.
  
• Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy era Conti, S. L., Thomas, I.-C., Hagedorn, J. C., Chung, B. I., Chertow, G. M., & Leppert, J. T. (2013). Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy era. BJU INTERNATIONAL, 112, 14-16.
  
• Utilization of renal mass biopsy in patients with renal cell carcinoma Leppert, J. T., Hanley, J., Wagner, T. H., Chung, B. I., Srinivas, S., & Saigal, C. S. (2013). Utilization of renal mass biopsy in patients with renal cell carcinoma. BJU INTERNATIONAL, 112, 14-14.
  
• Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial Heerspink, H. Jl., Chertow, G. M., Akizawa, T., Audhya, P., Bakris, G. L., & de Zeeuw, D. (2013). Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) trial. NEPHROLOGY DIALYSIS TRANSPLANTATION, 28(11), 2841-2850.
  
• High prevalence of type 2 diabetes among the urban middle class in Bangladesh Saquib, N., Khanam, M. A., Saquib, J., Anand, S., Chertow, G. M., & Cullen, M. R. (2013). High prevalence of type 2 diabetes among the urban middle class in Bangladesh. BMC PUBLIC HEALTH, 13.
  
• Piecewise Analysis of Patient Survival after Onset of AKI Zhang, J. H., Palevsky, P. M., Chertow, G. M., Hartigan, J., O'Connor, T. Z., & Zhou, B. (2013). Piecewise Analysis of Patient Survival after Onset of AKI. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 8(10), 1679-1684.
  
• Pre-ESRD Changes in Body Weight and Survival in Nursing Home Residents Starting Dialysis Stack, S., Chertow, G. M., Johansen, K. L., Si, Y., & Tamura, M. K. (2013). Pre-ESRD Changes in Body Weight and Survival in Nursing Home Residents Starting Dialysis. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 8(10), 1734-1740.
  
• Piecewise analysis of patient survival after onset of AKI. Zhang, J. H., Palevsky, P. M., Chertow, G. M., Hartigan, J., O'Connor, T. Z., & Zhou, B. (2013). Piecewise analysis of patient survival after onset of AKI. Clinical journal of the American Society of Nephrology , 8(10), 1679-1684.
  
• Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Erickson, K. F., Chertow, G. M., & Goldhaber-Fiebert, J. D. (2013). Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Annals of internal medicine, 159(6), 382-389.
  
• Cost-Effectiveness of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease Erickson, K. F., Chertow, G. M., & Goldhaber-Fiebert, J. D. (2013). Cost-Effectiveness of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease. ANNALS OF INTERNAL MEDICINE, 159(6), 382-?.
  
• Prevention of Contrast-Induced AKI: A Review of Published Trials and the Design of the Prevention of Serious Adverse Events following Angiography (PRESERVE) Trial Weisbord, S. D., Gallagher, M., Kaufman, J., Cass, A., Parikh, C. R., & Palevsky, P. M. (2013). Prevention of Contrast-Induced AKI: A Review of Published Trials and the Design of the Prevention of Serious Adverse Events following Angiography (PRESERVE) Trial. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 8(9), 1618-1631.
  
• Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial. Weisbord, S. D., Gallagher, M., Kaufman, J., Cass, A., Parikh, C. R., & Palevsky, P. M. (2013). Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial. Clinical journal of the American Society of Nephrology , 8(9), 1618-1631.
  
• Temporal Trends in the Incidence, Treatment, and Outcomes of Hip Fracture in Older Patients Initiating Dialysis in the United States Nair, S. S., Mitani, A. A., Goldstein, B. A., Chertow, G. M., Lowenberg, D. W., & Winkelmayer, W. C. (2013). Temporal Trends in the Incidence, Treatment, and Outcomes of Hip Fracture in Older Patients Initiating Dialysis in the United States. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 8(8), 1336-1342.
  
• Oh! What a tangled web we weave. Arora, N., & Chertow, G. M. (2013). Oh! What a tangled web we weave. Clinical journal of the American Society of Nephrology , 8(7), 1066-1067.
  
• Variation in Nephrologist Visits to Patients on Hemodialysis across Dialysis Facilities and Geographic Locations Erickson, K. F., Tan, K. B., Winkelmayer, W. C., Chertow, G. M., & Bhattacharya, J. (2013). Variation in Nephrologist Visits to Patients on Hemodialysis across Dialysis Facilities and Geographic Locations. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 8(6), 987-994.
  
• Cinacalcet for cardiovascular disease in patients undergoing dialysis. Chertow, G. M., & Parfrey, P. S. (2013). Cinacalcet for cardiovascular disease in patients undergoing dialysis. New England journal of medicine, 368(19), 1844-1845.
  
• Effect of frequent hemodialysis on residual kidney function Daugirdas, J. T., Greene, T., Rocco, M. V., Kaysen, G. A., Depner, T. A., & Kliger, A. S. (2013). Effect of frequent hemodialysis on residual kidney function. KIDNEY INTERNATIONAL, 83(5), 949-958.
  
• Effects of 6-Times-Weekly Versus 3-Times-Weekly Hemodialysis on Depressive Symptoms and Self-reported Mental Health: Frequent Hemodialysis Network (FHN) Trials Unruh, M. L., Larive, B., Chertow, G. M., Eggers, P. W., Garg, A. X., & Kimmel, P. L. (2013). Effects of 6-Times-Weekly Versus 3-Times-Weekly Hemodialysis on Depressive Symptoms and Self-reported Mental Health: Frequent Hemodialysis Network (FHN) Trials. AMERICAN JOURNAL OF KIDNEY DISEASES, 61(5), 748-758.
  
• Risk factors of short-term mortality after acute nonvariceal upper gastrointestinal bleeding in patients on dialysis: a population-based study Yang, J.-Y., Lee, T.-C., Montez-Rath, M. E., Chertow, G. M., & Winkelmayer, W. C. (2013). Risk factors of short-term mortality after acute nonvariceal upper gastrointestinal bleeding in patients on dialysis: a population-based study. BMC NEPHROLOGY, 14.
  
• TEMPORAL TRENDS IN THE INCIDENCE, TREATMENT, AND OUTCOMES OF HIP FRACTURE IN OLDER PATIENTS INITIATING DIALYSIS IN THE UNITED STATES. Nair, S. S., Mitani, A. A., Goldstein, B. A., Chertow, G. M., Lowenberg, D. W., & Winkelmayer, W. C. (2013). TEMPORAL TRENDS IN THE INCIDENCE, TREATMENT, AND OUTCOMES OF HIP FRACTURE IN OLDER PATIENTS INITIATING DIALYSIS IN THE UNITED STATES. AMERICAN JOURNAL OF KIDNEY DISEASES, 61(4), A93-A93.
  
• Cost-Effectiveness of Statins for Primary Cardiovascular Prevention in Chronic Kidney Disease Erickson, K. F., Japa, S., Owens, D. K., Chertow, G. M., Garber, A. M., & Goldhaber-Fiebert, J. D. (2013). Cost-Effectiveness of Statins for Primary Cardiovascular Prevention in Chronic Kidney Disease. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 61(12), 1250-1258.
  
• Longitudinal Measures of Serum Albumin and Prealbumin Concentrations in Incident Dialysis Patients: The Comprehensive Dialysis Study Dalrymple, L. S., Johansen, K. L., Chertow, G. M., Grimes, B., Anand, S., & Kaysen, G. A. (2013). Longitudinal Measures of Serum Albumin and Prealbumin Concentrations in Incident Dialysis Patients: The Comprehensive Dialysis Study. JOURNAL OF RENAL NUTRITION, 23(2), 91-97.
  
• Association of Physical Activity with Survival among Ambulatory Patients on Dialysis: The Comprehensive Dialysis Study Johansen, K. L., Kaysen, G. A., Dalrymple, L. S., Grimes, B. A., Glidden, D. V., & Chertow, G. M. (2013). Association of Physical Activity with Survival among Ambulatory Patients on Dialysis: The Comprehensive Dialysis Study. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 8(2), 248-253.
  
• Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON) de Zeeuw, D., Akizawa, T., Agarwal, R., Audhya, P., Bakrise, G. L., & Chertow, G. M. (2013). Rationale and Trial Design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events (BEACON). AMERICAN JOURNAL OF NEPHROLOGY, 37(3), 212-222.
  
• Trends in Acute Kidney Injury, Associated Use of Dialysis, and Mortality After Cardiac Surgery, 1999 to 2008 Lenihan, C. R., Montez-Rath, M. E., Mangano, C. Tm., Chertow, G. M., & Winkelmayer, W. C. (2013). Trends in Acute Kidney Injury, Associated Use of Dialysis, and Mortality After Cardiac Surgery, 1999 to 2008. ANNALS OF THORACIC SURGERY, 95(1), 20-28.
  
• Physical activity and self-reported symptoms of insomnia, restless legs syndrome, and depression: The comprehensive dialysis study Anand, S., Johansen, K. L., Grimes, B., Kaysen, G. A., Dalrymple, L. S., & Chertow, G. M. (2013). Physical activity and self-reported symptoms of insomnia, restless legs syndrome, and depression: The comprehensive dialysis study. HEMODIALYSIS INTERNATIONAL, 17(1), 50-58.
  
• Risk factors of short-term mortality after acute nonvariceal upper gastrointestinal bleeding in patients on dialysis: a population-based study. Yang, J.-Y., Lee, T.-C., Montez-Rath, M. E., Chertow, G. M., & Winkelmayer, W. C. (2013). Risk factors of short-term mortality after acute nonvariceal upper gastrointestinal bleeding in patients on dialysis: a population-based study. BMC nephrology, 14, 97-?.
  
• A transcriptional blueprint for human and murine diabetic kidney disease. Bhalla, V., Velez, M.-G., & Chertow, G. M. (2013). A transcriptional blueprint for human and murine diabetic kidney disease. Diabetes, 62(1), 31-33.
  
• Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. Chertow, G. M., Block, G. A., Correa-Rotter, R., Drüeke, T. B., Floege, J., & Parfrey, P. S. (2012). Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. New England journal of medicine, 367(26), 2482-2494.
  
• Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis Chertow, G. M., Block, G. A., Correa-Rotter, R., Drueeke, T. B., Floege, J., & Parfrey, P. S. (2012). Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis. NEW ENGLAND JOURNAL OF MEDICINE, 367(26), 2482-2494.
  
• Venous Thromboembolism Yet Another Cardiovascular Complication of Chronic Kidney Disease? Chertow, G. M., & Mahaffey, K. W. (2012). Venous Thromboembolism Yet Another Cardiovascular Complication of Chronic Kidney Disease?. CIRCULATION, 126(16), 1937-1938.
  
• Bardoxolone Methyl Decreases Megalin and Activates Nrf2 in the Kidney Reisman, S. A., Chertow, G. M., Hebbar, S., Vaziri, N. D., Ward, K. W., & Meyer, C. J. (2012). Bardoxolone Methyl Decreases Megalin and Activates Nrf2 in the Kidney. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 23(10), 1663-1673.
  
• Individualized reduction in dialysate sodium in conventional in-center hemodialysis Arramreddy, R., Sun, S. J., Mendoza, J. M., Chertow, G. M., & Schiller, B. (2012). Individualized reduction in dialysate sodium in conventional in-center hemodialysis. HEMODIALYSIS INTERNATIONAL, 16(4), 473-480.
  
• Donor Recipient Sex Mismatch in Kidney Transplantation Tan, J. C., Kim, J. P., Chertow, G. M., Grumet, F. C., & Desai, M. (2012). Donor Recipient Sex Mismatch in Kidney Transplantation. GENDER MEDICINE, 9(5), 335-347.
  
• Effects of Phosphate Binders in Moderate CKD Block, G. A., Wheeler, D. C., Persky, M. S., Kestenbaum, B., Ketteler, M., & Chertow, G. M. (2012). Effects of Phosphate Binders in Moderate CKD. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 23(8), 1407-1415.
  
• Frailty, Dialysis Initiation, and Mortality in End-Stage Renal Disease Bao, Y., Dalrymple, L., Chertow, G. M., Kaysen, G. A., & Johansen, K. L. (2012). Frailty, Dialysis Initiation, and Mortality in End-Stage Renal Disease. ARCHIVES OF INTERNAL MEDICINE, 172(14), 1071-1077.
  
• Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial Chertow, G. M., Correa-Rotter, R., Block, G. A., Drueke, T. B., Floege, J., & Parfrey, P. S. (2012). Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial. NEPHROLOGY DIALYSIS TRANSPLANTATION, 27(7), 2872-2879.
  
• Homelessness and CKD: A Cohort Study Hall, Y. N., Choi, A. I., Himmelfarb, J., Chertow, G. M., & Bindman, A. B. (2012). Homelessness and CKD: A Cohort Study. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 7(7), 1094-1102.
  
• The effect of frequent hemodialysis on nutrition and body composition: Frequent Hemodialysis Network Trial Kaysen, G. A., Greene, T., Larive, B., Mehta, R. L., Lindsay, R. M., & Chertow, G. M. (2012). The effect of frequent hemodialysis on nutrition and body composition: Frequent Hemodialysis Network Trial. KIDNEY INTERNATIONAL, 82(1), 90-99.
  
• Validation of Reported Predialysis Nephrology Care of Older Patients Initiating Dialysis Kim, J. P., Desai, M., Chertow, G. M., & Winkelmayer, W. C. (2012). Validation of Reported Predialysis Nephrology Care of Older Patients Initiating Dialysis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 23(6), 1078-1085.
  
• Toward the optimal dose metric in continuous renal replacement therapy Claure-Del Granado, R., Macedo, E., Chertow, G. M., Soroko, S., Himmelfarb, J., & Mehta, R. L. (2012). Toward the optimal dose metric in continuous renal replacement therapy. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 35(6), 413-424.
  
• Design of Clinical Trials in Acute Kidney Injury: A Report from an NIDDK Workshop-Prevention Trials Okusa, M. D., Molitoris, B. A., Palevsky, P. M., Chinchilli, V. M., Liu, K. D., & Star, R. A. (2012). Design of Clinical Trials in Acute Kidney Injury: A Report from an NIDDK Workshop-Prevention Trials. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 7(5), 851-855.
  
• Design of Clinical Trials in AKI: A Report from an NIDDK Workshop. Trials of Patients with Sepsis and in Selected Hospital Settings Molitoris, B. A., Okusa, M. D., Palevsky, P. M., Chawla, L. S., Kaufman, J. S., & Star, R. A. (2012). Design of Clinical Trials in AKI: A Report from an NIDDK Workshop. Trials of Patients with Sepsis and in Selected Hospital Settings. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 7(5), 856-860.
  
• Challenges to enrollment and randomization of the frequent hemodialysis network (FHN) daily trial Sergeyeva, O., Gorodetskaya, I., Ramos, R., Schiller, B. M., Larive, B., & Levin, N. W. (2012). Challenges to enrollment and randomization of the frequent hemodialysis network (FHN) daily trial. JOURNAL OF NEPHROLOGY, 25(3), 302-309.
  
• Design of Clinical Trials in Acute Kidney Injury: Report from an NIDDK Workshop on Trial Methodology Palevsky, P. M., Molitoris, B. A., Okusa, M. D., Levin, A., Waikar, S. S., & Star, R. A. (2012). Design of Clinical Trials in Acute Kidney Injury: Report from an NIDDK Workshop on Trial Methodology. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 7(5), 844-850.
  
• Ongoing Clinical Trials in AKI Faubel, S., Chawla, L. S., Chertow, G. M., Goldstein, S. L., Jaber, B. L., & Liu, K. D. (2012). Ongoing Clinical Trials in AKI. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 7(5), 861-873.
  
• Effects of Six versus Three Times per Week Hemodialysis on Physical Performance, Health, and Functioning: Frequent Hemodialysis Network (FHN) Randomized Trials Hall, Y. N., Larive, B., Painter, P., Kaysen, G. A., Lindsay, R. M., & Chertow, G. M. (2012). Effects of Six versus Three Times per Week Hemodialysis on Physical Performance, Health, and Functioning: Frequent Hemodialysis Network (FHN) Randomized Trials. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 7(5), 782-794.
  
• Effects of Frequent Hemodialysis on Measures of CKD Mineral and Bone Disorder Daugirdas, J. T., Chertow, G. M., Larive, B., Pierratos, A., Greene, T., & Kliger, A. S. (2012). Effects of Frequent Hemodialysis on Measures of CKD Mineral and Bone Disorder. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 23(4), 727-738.
  
• Self-reported symptoms in patients on hemodialysis with moderate to severe secondary hyperparathyroidism receiving combined therapy with cinacalcet and low-dose vitamin D sterols Chertow, G. M., Lu, Z. J., Xu, X., Knight, T. G., Goodman, W. G., & Block, G. A. (2012). Self-reported symptoms in patients on hemodialysis with moderate to severe secondary hyperparathyroidism receiving combined therapy with cinacalcet and low-dose vitamin D sterols. HEMODIALYSIS INTERNATIONAL, 16(2), 188-197.
  
• Trends in Acute Nonvariceal Upper Gastrointestinal Bleeding in Dialysis Patients Yang, J.-Y., Lee, T.-C., Montez-Rath, M. E., Paik, J., Chertow, G. M., & Winkelmayer, W. C. (2012). Trends in Acute Nonvariceal Upper Gastrointestinal Bleeding in Dialysis Patients. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 23(3), 495-506.
  
• Determinants of Left Ventricular Mass in Patients on Hemodialysis Frequent Hemodialysis Network (FHN) Trials Chan, C. T., Greene, T., Chertow, G. M., Kliger, A. S., Stokes, J. B., & Rajagopalan, S. (2012). Determinants of Left Ventricular Mass in Patients on Hemodialysis Frequent Hemodialysis Network (FHN) Trials. CIRCULATION-CARDIOVASCULAR IMAGING, 5(2), 251-261.
  
• Prospective Safety Study of Bardoxolone Methyl in Patients with Type 2 Diabetes Mellitus, End-Stage Renal Disease and Peritoneal Dialysis Warnock, D. G., Hebbar, S., Bargman, J., Burkart, J., Davies, S., & Chertow, G. M. (2012). Prospective Safety Study of Bardoxolone Methyl in Patients with Type 2 Diabetes Mellitus, End-Stage Renal Disease and Peritoneal Dialysis. PERITONEAL DIALYSIS - STATE-OF-THE-ART 2012, 178, 157-163.
  
• Acute Kidney Injury and Mortality in Hospitalized Patients Wang, H. E., Muntner, P., Chertow, G. M., & Warnock, D. G. (2012). Acute Kidney Injury and Mortality in Hospitalized Patients. AMERICAN JOURNAL OF NEPHROLOGY, 35(4), 349-355.
  
• Validity of Surrogate Measures for Functional Nephron Mass Tan, J. C., Paik, J., Chertow, G. M., Grumet, F. C., Busque, S., & Desai, M. (2011). Validity of Surrogate Measures for Functional Nephron Mass. TRANSPLANTATION, 92(12), 1335-1341.
  
• Vitamin D deficiency, self-reported physical activity and health-related quality of life: the Comprehensive Dialysis Study Anand, S., Kaysen, G. A., Chertow, G. M., Johansen, K. L., Grimes, B., & Tamura, M. K. (2011). Vitamin D deficiency, self-reported physical activity and health-related quality of life: the Comprehensive Dialysis Study. NEPHROLOGY DIALYSIS TRANSPLANTATION, 26(11), 3683-3688.
  
• Association of Self-reported Physical Activity With Laboratory Markers of Nutrition and Inflammation: The Comprehensive Dialysis Study Anand, S., Chertow, G. M., Johansen, K. L., Grimes, B., Tamura, M. K., & Kaysen, G. A. (2011). Association of Self-reported Physical Activity With Laboratory Markers of Nutrition and Inflammation: The Comprehensive Dialysis Study. JOURNAL OF RENAL NUTRITION, 21(6), 429-437.
  
• The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial Rocco, M. V., Lockridge, R. S., Beck, G. J., Eggers, P. W., Gassman, J. J., & Kliger, A. S. (2011). The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. KIDNEY INTERNATIONAL, 80(10), 1080-1091.
  
• Chronic Kidney Disease and Cardiovascular Therapeutics Time to Close the Evidence Gaps Chang, T. I., & Chertow, G. M. (2011). Chronic Kidney Disease and Cardiovascular Therapeutics Time to Close the Evidence Gaps. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 58(11), 1162-1164.
  
• Model to Predict Mortality in Critically Ill Adults with Acute Kidney Injury Demirjian, S., Chertow, G. M., Zhang, J. H., O'Connor, T. Z., Vitale, J., & Palevsky, P. M. (2011). Model to Predict Mortality in Critically Ill Adults with Acute Kidney Injury. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 6(9), 2114-2120.
  
• Living donor evaluation and exclusion: the Stanford experience Lapasia, J. B., Kong, S.- yee, Busque, S., Scandling, J. D., Chertow, G. M., & Tan, J. C. (2011). Living donor evaluation and exclusion: the Stanford experience. CLINICAL TRANSPLANTATION, 25(5), 697-704.
  
• Predialysis Nephrology Care of Older Patients Approaching End-stage Renal Disease Winkelmayer, W. C., Liu, J., Chertow, G. M., & Tamura, M. K. (2011). Predialysis Nephrology Care of Older Patients Approaching End-stage Renal Disease. ARCHIVES OF INTERNAL MEDICINE, 171(15), 1371-1378.
  
• Assessment and management of vascular disease risk in patients with chronic kidney disease Brown, W. V., Bakris, G., Lerma, E., & Chertow, G. (2011). Assessment and management of vascular disease risk in patients with chronic kidney disease. JOURNAL OF CLINICAL LIPIDOLOGY, 5(4), 251-260.
  
• Angiotensin Converting Enzyme Inhibitors in Hemodialysis Chang, T. I., Shilane, D., Brunelli, S. M., Cheung, A. K., Chertow, G. M., & Winkelmayer, W. C. (2011). Angiotensin Converting Enzyme Inhibitors in Hemodialysis. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 20, S15-S15.
  
• Intradialytic Hypotension and Vascular Access Thrombosis Chang, T. I., Paik, J., Greene, T., Desai, M., Bech, F., & Chertow, G. M. (2011). Intradialytic Hypotension and Vascular Access Thrombosis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 22(8), 1526-1533.
  
• Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis Chang, T. I., Shilane, D., Brunelli, S. M., Cheung, A. K., Chertow, G. M., & Winkelmayer, W. C. (2011). Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis. AMERICAN HEART JOURNAL, 162(2), 324-330.
  
• Burden on caregivers as perceived by hemodialysis patients in the Frequent Hemodialysis Network (FHN) trials Suri, R. S., Larive, B., Garg, A. X., Hall, Y. N., Pierratos, A., & Kliger, A. S. (2011). Burden on caregivers as perceived by hemodialysis patients in the Frequent Hemodialysis Network (FHN) trials. NEPHROLOGY DIALYSIS TRANSPLANTATION, 26(7), 2316-2322.
  
• Risk of Cardiovascular Events after Infection-Related Hospitalizations in Older Patients on Dialysis Dalrymple, L. S., Mohammed, S. M., Mu, Y., Johansen, K. L., Chertow, G. M., & Nguyen, D. V. (2011). Risk of Cardiovascular Events after Infection-Related Hospitalizations in Older Patients on Dialysis. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 6(7), 1708-1713.
  
• Incidence, Correlates, and Consequences of Acute Kidney Injury in Patients With Pulmonary Arterial Hypertension Hospitalized With Acute Right-Side Heart Failure Haddad, F., Fuh, E., Peterson, T., Skhiri, M., Kudelko, K. T., & Zamanian, R. T. (2011). Incidence, Correlates, and Consequences of Acute Kidney Injury in Patients With Pulmonary Arterial Hypertension Hospitalized With Acute Right-Side Heart Failure. JOURNAL OF CARDIAC FAILURE, 17(7), 533-539.
  
• Update in Nephrology: Evidence Published in 2010 Arora, N., & Chertow, G. M. (2011). Update in Nephrology: Evidence Published in 2010. ANNALS OF INTERNAL MEDICINE, 154(12), 824-U79.
  
• Modeled Urea Distribution Volume and Mortality in the HEMO Study Daugirdas, J. T., Greene, T., Depner, T. A., Levin, N. W., & Chertow, G. M. (2011). Modeled Urea Distribution Volume and Mortality in the HEMO Study. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 6(5), 1129-1138.
  
• Dialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach? Mendoza, J. M., Sun, S., Chertow, G. M., Moran, J., Doss, S., & Schiller, B. (2011). Dialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach?. NEPHROLOGY DIALYSIS TRANSPLANTATION, 26(4), 1281-1287.
  
• The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis Raggi, P., Chertow, G. M., Torres, P. U., Csiky, B., Naso, A., & Floege, J. (2011). The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. NEPHROLOGY DIALYSIS TRANSPLANTATION, 26(4), 1327-1339.
  
• Racial Ethnic Differences in Rates and Determinants of Deceased Donor Kidney Transplantation Hall, Y. N., Choi, A. I., Xu, P., O'Hare, A. M., & Chertow, G. M. (2011). Racial Ethnic Differences in Rates and Determinants of Deceased Donor Kidney Transplantation. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 22(4), 743-751.
  
• Aspirin and Arteriovenous Graft Thrombosis in Hemodialysis: Just What the Doctor Ordered? Bech, F. R., & Chertow, G. M. (2011). Aspirin and Arteriovenous Graft Thrombosis in Hemodialysis: Just What the Doctor Ordered?. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 22(4), 595-597.
  
• The 2011 ESRD Prospective Payment System: An Uncontrolled Experiment Winkelmayer, W. C., & Chertow, G. M. (2011). The 2011 ESRD Prospective Payment System: An Uncontrolled Experiment. AMERICAN JOURNAL OF KIDNEY DISEASES, 57(4), 542-546.
  
• Effluent Volume in Continuous Renal Replacement Therapy Overestimates the Delivered Dose of Dialysis Claure-Del Gramdo, R., Macedo, E., Chertow, G. M., Soroko, S., Himmelfarb, J., & Mehta, R. L. (2011). Effluent Volume in Continuous Renal Replacement Therapy Overestimates the Delivered Dose of Dialysis. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 6(3), 467-475.
  
• World Kidney Day 2011 Hostetter, T. H., Kochis, D. J., Shaffer, R. N., Chertow, G., Harmon, W. E., & Winkelmayer, W. C. (2011). World Kidney Day 2011. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 22(3), 397-398.
  
• Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease Mehta, R. L., Bouchard, J., Soroko, S. B., Ikizler, T. A., Paganini, E. P., & Himmelfarb, J. (2011). Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease. INTENSIVE CARE MEDICINE, 37(2), 241-248.
  
• Vascular Risk Factors and Cognitive Impairment in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study Tamura, M. K., Xie, D., Yaffe, K., Cohen, D. L., Teal, V., & Go, A. S. (2011). Vascular Risk Factors and Cognitive Impairment in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 6(2), 248-256.
  
• Systolic blood pressure and mortality in prevalent haemodialysis patients in the HEMO study Chang, T. I., Friedman, G. D., Cheung, A. K., Greene, T., Desai, M., & Chertow, G. M. (2011). Systolic blood pressure and mortality in prevalent haemodialysis patients in the HEMO study. JOURNAL OF HUMAN HYPERTENSION, 25(2), 98-105.
  
• Baseline Physical Performance, Health, and Functioning of Participants in the Frequent Hemodialysis Network (FHN) Trial Kaysen, G. A., Larive, B., Painter, P., Craig, A., Lindsay, R. M., & Chertow, G. M. (2011). Baseline Physical Performance, Health, and Functioning of Participants in the Frequent Hemodialysis Network (FHN) Trial. AMERICAN JOURNAL OF KIDNEY DISEASES, 57(1), 101-112.
  
• Baseline Characteristics of Participants in the Frequent Hemodialysis Network (FHN) Daily and Nocturnal Trials Rocco, M. V., Larive, B., Eggers, P. W., Beck, G. J., Chertow, G. M., & Kliger, A. S. (2011). Baseline Characteristics of Participants in the Frequent Hemodialysis Network (FHN) Daily and Nocturnal Trials. AMERICAN JOURNAL OF KIDNEY DISEASES, 57(1), 90-100.
  
• The Phosphate Binder Equivalent Dose Daugirdas, J. T., Finn, W. F., Emmett, M., & Chertow, G. M. (2011). The Phosphate Binder Equivalent Dose. SEMINARS IN DIALYSIS, 24(1), 41-49.
  
• RELATIONSHIP OF BODY SIZE AND MORTALITY AMONG US ASIANS AND PACIFIC ISLANDERS ON DIALYSIS Hall, Y. N., Xu, P., & Chertow, G. M. (2011). RELATIONSHIP OF BODY SIZE AND MORTALITY AMONG US ASIANS AND PACIFIC ISLANDERS ON DIALYSIS. ETHNICITY & DISEASE, 21(1), 40-46.
  
• End-stage Renal Disease. Abbasi, M., Chertow, G., & Hall, Y. (2010). End-stage Renal Disease. American family physician, 82(12), 1512-?.
  
• In-Center Hemodialysis Six Times per Week versus Three Times per Week Chertow, G. M., Levin, N. W., Beck, G. J., Depner, T. A., Eggers, P. W., & Kliger, A. S. (2010). In-Center Hemodialysis Six Times per Week versus Three Times per Week. NEW ENGLAND JOURNAL OF MEDICINE, 363(24), 2287-2300.
  
• Low level of self-reported physical activity in ambulatory patients new to dialysis Johansen, K. L., Chertow, G. M., Kutner, N. G., Dalrymple, L. S., Grimes, B. A., & Kaysen, G. A. (2010). Low level of self-reported physical activity in ambulatory patients new to dialysis. KIDNEY INTERNATIONAL, 78(11), 1164-1170.
  
• Blood Pressure Control in Type 2 Diabetes Mellitus Chang, T. I., Cheung, A. K., & Chertow, G. M. (2010). Blood Pressure Control in Type 2 Diabetes Mellitus. AMERICAN JOURNAL OF KIDNEY DISEASES, 56(6), 1029-1031.
  
• Curbing the Use of Ultrasonography in the Diagnosis of Acute Kidney Injury Penny Wise or Pound Foolish? Liu, K. D., & Chertow, G. M. (2010). Curbing the Use of Ultrasonography in the Diagnosis of Acute Kidney Injury Penny Wise or Pound Foolish?. ARCHIVES OF INTERNAL MEDICINE, 170(21), 1907-1908.
  
• Off-Label Use of Phosphate Binders in Non-Dialysis-Dependent CKD Winkelmayer, W. C., & Chertow, G. M. (2010). Off-Label Use of Phosphate Binders in Non-Dialysis-Dependent CKD. AMERICAN JOURNAL OF KIDNEY DISEASES, 56(5), 813-816.
  
• Determinants of Cardiac Autonomic Dysfunction in ESRD Chan, C. T., Levin, N. W., Chertow, G. M., Lariye, B., Schulman, G., & Kotanko, P. (2010). Determinants of Cardiac Autonomic Dysfunction in ESRD. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 5(10), 1821-1827.
  
• Updated comorbidity assessments and outcomes in prevalent hemodialysis patients Chang, T. I., Paik, J., Greene, T., Miskulin, D. C., & Chertow, G. M. (2010). Updated comorbidity assessments and outcomes in prevalent hemodialysis patients. HEMODIALYSIS INTERNATIONAL, 14(4), 478-485.
  
• Can Rescaling Dose of Dialysis to Body Surface Area in the HEMO Study Explain the Different Responses to Dose in Women versus Men? Daugirdas, J. T., Greene, T., Chertow, G. M., & Depner, T. A. (2010). Can Rescaling Dose of Dialysis to Body Surface Area in the HEMO Study Explain the Different Responses to Dose in Women versus Men?. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 5(9), 1628-1636.
  
• On the relative safety of intravenous iron formulations: New answers, new questions Chertow, G. M., & Winkelmayer, W. C. (2010). On the relative safety of intravenous iron formulations: New answers, new questions. AMERICAN JOURNAL OF HEMATOLOGY, 85(9), 643-644.
  
• Infection-Related Hospitalizations in Older Patients With ESRD Dalrymple, L. S., Johansen, K. L., Chertow, G. M., Cheng, S.-C., Grimes, B., & Kaysen, G. A. (2010). Infection-Related Hospitalizations in Older Patients With ESRD. AMERICAN JOURNAL OF KIDNEY DISEASES, 56(3), 522-530.
  
• Prevalence and Correlates of Cognitive Impairment in Hemodialysis Patients: The Frequent Hemodialysis Network Trials Tamura, M. K., Larive, B., Unruh, M. L., Stokes, J. B., Nissenson, A., & Chertow, G. M. (2010). Prevalence and Correlates of Cognitive Impairment in Hemodialysis Patients: The Frequent Hemodialysis Network Trials. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 5(8), 1429-1438.
  
• Vitamin D deficiency and frailty in older Americans Wilhelm-Leen, E. R., Hall, Y. N., DEBOER, I. H., & Chertow, G. M. (2010). Vitamin D deficiency and frailty in older Americans. JOURNAL OF INTERNAL MEDICINE, 268(2), 171-180.
  
• Hyperparathyroidism with hypercalcaemia in chronic kidney disease: primary or tertiary? Lunn, M. R., Muñoz Mendoza, J., Pasche, L. J., Norton, J. A., Ayco, A. L., & Chertow, G. M. (2010). Hyperparathyroidism with hypercalcaemia in chronic kidney disease: primary or tertiary?. NDT plus, 3(4), 366-371.
  
• Reexploring Differences among For-Profit and Nonprofit Dialysis Providers Lee, D. Kk., Chertow, G. M., & Zenios, S. A. (2010). Reexploring Differences among For-Profit and Nonprofit Dialysis Providers. HEALTH SERVICES RESEARCH, 45(3), 633-646.
  
• Study design and subject baseline characteristics in the ADVANCE study: effects of cinacalcet on vascular calcification in haemodialysis patients Floege, J., Raggi, P., Block, G. A., Torres, P. U., Csiky, B., & Chertow, G. M. (2010). Study design and subject baseline characteristics in the ADVANCE study: effects of cinacalcet on vascular calcification in haemodialysis patients. NEPHROLOGY DIALYSIS TRANSPLANTATION, 25(6), 1916-1923.
  
• Kidney Disease, Hospitalized Hypertension, and Cardiovascular Events: Cause or Consequence? Chertow, G. M., & Chang, T. I. (2010). Kidney Disease, Hospitalized Hypertension, and Cardiovascular Events: Cause or Consequence?. CIRCULATION, 121(20), 2160-2161.
  
• Chronic Kidney Disease in the Urban Poor Hall, Y. N., Choi, A. I., Chertow, G. M., & Bindman, A. B. (2010). Chronic Kidney Disease in the Urban Poor. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 5(5), 828-835.
  
• Weekend Hospital Admission, Acute Kidney Injury, and Mortality James, M. T., Wald, R., Bell, C. M., Tonelli, M., Hemmelgarn, B. R., & Chertow, G. M. (2010). Weekend Hospital Admission, Acute Kidney Injury, and Mortality. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 21(5), 845-851.
  
• Shorter dialysis times are associated with higher mortality among incident hemodialysis patients Brunelli, S. M., Chertow, G. M., Ankers, E. D., Lowrie, E. G., & Thadhani, R. (2010). Shorter dialysis times are associated with higher mortality among incident hemodialysis patients. KIDNEY INTERNATIONAL, 77(7), 630-636.
  
• Standard Kt/V-urea: a method of calculation that includes effects of fluid removal and residual kidney clearance Daugirdas, J. T., Depner, T. A., Greene, T., Levin, N. W., Chertow, G. M., & Rocco, M. V. (2010). Standard Kt/V-urea: a method of calculation that includes effects of fluid removal and residual kidney clearance. KIDNEY INTERNATIONAL, 77(7), 637-644.
  
• GFR estimating equations, CKD prevalence and the public health Chang, T. I., & Chertow, G. M. (2010). GFR estimating equations, CKD prevalence and the public health. JOURNAL OF INTERNAL MEDICINE, 267(4), 354-356.
  
• The elderly patients on hemodialysis. Anand, S., Kurella Tamura, M., & Chertow, G. M. (2010). The elderly patients on hemodialysis. Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 62(1), 87-101.
  
• Projected Effect of Dietary Salt Reductions on Future Cardiovascular Disease Bibbins-Domingo, K., Chertow, G. M., Coxson, P. G., Moran, A., Lightwood, J. M., & Goldman, L. (2010). Projected Effect of Dietary Salt Reductions on Future Cardiovascular Disease. NEW ENGLAND JOURNAL OF MEDICINE, 362(7), 590-599.
  
• Comparison of methods for estimating glomerular filtration rate in critically ill patients with acute kidney injury Bouchard, J., Macedo, E., Soroko, S., Chertow, G. M., Himmelfarb, J., & Mehta, R. L. (2010). Comparison of methods for estimating glomerular filtration rate in critically ill patients with acute kidney injury. NEPHROLOGY DIALYSIS TRANSPLANTATION, 25(1), 102-107.
  
• Effects of Reduced Intradialytic Urea Generation Rate and Residual Renal Clearance on Modeled Urea Distribution Volume and Kt/V in Conventional, Daily, and Nocturnal Dialysis Daugirdas, J. T., Depner, T. A., Greene, T., Levin, N. W., Chertow, G. M., & Stokes, J. B. (2010). Effects of Reduced Intradialytic Urea Generation Rate and Residual Renal Clearance on Modeled Urea Distribution Volume and Kt/V in Conventional, Daily, and Nocturnal Dialysis. SEMINARS IN DIALYSIS, 23(1), 19-24.
  
• Use of Standard Kt/V for Comparison of Efficiency Between Continuous Renal Replacement Therapies and Intermittent Hemodialysis in Acute Kidney Injury Claure-Del Granado, R., Macedo, E., Soroko, S., Chertow, G. M., Himmelfarb, J., & Mehta, R. L. (2010). Use of Standard Kt/V for Comparison of Efficiency Between Continuous Renal Replacement Therapies and Intermittent Hemodialysis in Acute Kidney Injury. BLOOD PURIFICATION, 30(3), 229-230.
  
• End-stage renal disease. Abbasi, M. A., Chertow, G. M., & Hall, Y. N. (2010). End-stage renal disease. Clinical evidence.
  
• Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients Macedo, E., Bouchard, J., Soroko, S. H., Chertow, G. M., Himmelfarb, J., & Mehta, R. L. (2010). Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients. CRITICAL CARE, 14(3).
  
• Preexisting Chronic Kidney Disease: A Potential for Improved Outcomes from Acute Kidney Injury Khosla, N., Soroko, S. B., Chertow, G. M., Himmelfarb, J., Ikizler, T. A., & Mehta, R. L. (2009). Preexisting Chronic Kidney Disease: A Potential for Improved Outcomes from Acute Kidney Injury. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 4(12), 1914-1919.
  
• Medication errors in chronic kidney disease: one piece in the patient safety puzzle Fink, J. C., & Chertow, G. M. (2009). Medication errors in chronic kidney disease: one piece in the patient safety puzzle. KIDNEY INTERNATIONAL, 76(11), 1123-1125.
  
• Increased fluid intake does not augment capacity to lay down new collagen in nursing home residents at risk for pressure ulcers: A randomized, controlled clinical trial Stotts, N. A., Hopf, H. W., Kayser-Jones, J., Chertow, G. M., Cooper, B. A., & Wu, H.-S. (2009). Increased fluid intake does not augment capacity to lay down new collagen in nursing home residents at risk for pressure ulcers: A randomized, controlled clinical trial. WOUND REPAIR AND REGENERATION, 17(6), 780-788.
  
• Fetuin-A and Change in Body Composition in Older Persons Ix, J. H., Wassel, C. L., Chertow, G. M., Koster, A., Johnson, K. C., & Shlipak, M. G. (2009). Fetuin-A and Change in Body Composition in Older Persons. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 94(11), 4492-4498.
  
• Functional Status of Elderly Adults before and after Initiation of Dialysis Tamura, M. K., Covinsky, K. E., Chertow, G. M., Yaffe, K., Landefeld, C. S., & McCulloch, C. E. (2009). Functional Status of Elderly Adults before and after Initiation of Dialysis. NEW ENGLAND JOURNAL OF MEDICINE, 361(16), 1539-1547.
  
• Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease Lo, L. J., Go, A. S., Chertow, G. M., McCulloch, C. E., Fan, D., & Hsu, C.- yuan. (2009). Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. KIDNEY INTERNATIONAL, 76(8), 893-899.
  
• Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury Bouchard, J., Soroko, S. B., Chertow, G. M., Himmelfarb, J., Ikizler, T. A., & Mehta, R. L. (2009). Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. KIDNEY INTERNATIONAL, 76(4), 422-427.
  
• Characteristics of Uninsured Americans with Chronic Kidney Disease Hall, Y. N., Rodriguez, R. A., Boyko, E. J., Chertow, G. M., & O'Hare, A. M. (2009). Characteristics of Uninsured Americans with Chronic Kidney Disease. JOURNAL OF GENERAL INTERNAL MEDICINE, 24(8), 917-922.
  
• Frailty and Chronic Kidney Disease: The Third National Health and Nutrition Evaluation Survey Wilhelm-Leen, E. R., Hall, Y. N., Tamura, M. K., & Chertow, G. M. (2009). Frailty and Chronic Kidney Disease: The Third National Health and Nutrition Evaluation Survey. AMERICAN JOURNAL OF MEDICINE, 122(7), 664-U86.
  
• A randomized double-blind pilot study of serum phosphorus normalization in chronic kidney disease: A new paradigm for clinical outcomes studies in nephrology Block, G. A., Persky, M. S., Ketteler, M., Kestenbaum, B., Thadhani, R., & Wheeler, D. C. (2009). A randomized double-blind pilot study of serum phosphorus normalization in chronic kidney disease: A new paradigm for clinical outcomes studies in nephrology. HEMODIALYSIS INTERNATIONAL, 13(3), 360-362.
  
• The relationship between laboratory-based outcome measures and mortality in end-stage renal disease: A systematic review Desai, A. A., Nissenson, A., Chertow, G. M., Farid, M., Singh, I., & Spiegel, B. Mr. (2009). The relationship between laboratory-based outcome measures and mortality in end-stage renal disease: A systematic review. HEMODIALYSIS INTERNATIONAL, 13(3), 347-359.
  
• Phosphorus binders and survival: need for randomized trials Ix, J. H., & Chertow, G. M. (2009). Phosphorus binders and survival: need for randomized trials. NATURE REVIEWS NEPHROLOGY, 5(7), 368-370.
  
• Melamine nephrotoxicity: an emerging epidemic in an era of globalization Bhalla, V., Grimm, P. C., Chertow, G. M., & Pao, A. C. (2009). Melamine nephrotoxicity: an emerging epidemic in an era of globalization. KIDNEY INTERNATIONAL, 75(8), 774-779.
  
• IMPACT OF CINACALCET THERAPY ON PATIENT-REPORTED SYMPTOMS IN PATIENTS WITH MODERATE TO SEVERE SECONDARY HYPERPARATHYROIDISM Block, G. A., Xu, X., Lu, Z. J., Bushinsky, D. A., Goodman, W., & Chertow, G. M. (2009). IMPACT OF CINACALCET THERAPY ON PATIENT-REPORTED SYMPTOMS IN PATIENTS WITH MODERATE TO SEVERE SECONDARY HYPERPARATHYROIDISM. AMERICAN JOURNAL OF KIDNEY DISEASES, 53(4), A29-A29.
  
• Cautious Optimism Concerning Long-Term Safety of Kidney Donation. Tan, J. C., & Chertow, G. M. (2009). Cautious Optimism Concerning Long-Term Safety of Kidney Donation. NEW ENGLAND JOURNAL OF MEDICINE, 360(5), 522-523.
  
• Choroidopathy and kidney disease: a case report and review of the literature. Kamdar, N. V., Erko, A., Ehrlich, J. S., Kim, J. W., Kambham, N., & Chertow, G. M. (2009). Choroidopathy and kidney disease: a case report and review of the literature. Cases journal, 2, 7425-?.
  
• Regional Variation in Kidney Transplant Outcomes: Trends Over Time Chakkera, H. A., Chertow, G. M., O'Hare, A. M., Amend, W. J., & Gonwa, T. A. (2009). Regional Variation in Kidney Transplant Outcomes: Trends Over Time. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 4(1), 152-159.
  
• Intensity of renal replacement therapy in acute kidney injury: perspective from within the Acute Renal Failure Trial Network Study Palevsky, P. M., O'Connor, T. Z., Chertow, G. M., Crowley, S. T., Zhang, J. H., & Kellum, J. A. (2009). Intensity of renal replacement therapy in acute kidney injury: perspective from within the Acute Renal Failure Trial Network Study. CRITICAL CARE, 13(4).
  
• An Empiric Estimate of the Value of Life: Updating the Renal Dialysis Cost-Effectiveness Standard Lee, C. P., Chertow, G. M., & Zenios, S. A. (2009). An Empiric Estimate of the Value of Life: Updating the Renal Dialysis Cost-Effectiveness Standard. VALUE IN HEALTH, 12(1), 80-87.
  
• Neighborhood poverty and kidney transplantation among US Asians and Pacific Islanders with end-stage renal disease Halla, Y. N., O'Harea, A. M., Younga, B. A., Boyko, E. J., & Chertow, G. M. (2008). Neighborhood poverty and kidney transplantation among US Asians and Pacific Islanders with end-stage renal disease. AMERICAN JOURNAL OF TRANSPLANTATION, 8(11), 2402-2409.
  
• Optimal Initiation and Management of Dialysis Therapy Lee, C. P., Chertow, G. M., & Zenios, S. A. (2008). Optimal Initiation and Management of Dialysis Therapy. OPERATIONS RESEARCH, 56(6), 1428-1449.
  
• Management of acute kidney injury in the intensive care unit - A cost-effectiveness analysis of daily vs alternate-day hemodialysis Desai, A. A., Baras, J., Berk, B. B., Nakajima, A., Garber, A. M., & Chertow, G. M. (2008). Management of acute kidney injury in the intensive care unit - A cost-effectiveness analysis of daily vs alternate-day hemodialysis. ARCHIVES OF INTERNAL MEDICINE, 168(16), 1761-1767.
  
• Surface-Area-Normalized Kt/V: A Method of Rescaling Dialysis Dose to Body Surface Area-Implications for Different-Size Patients by Gender Daugirdas, J. T., Depner, T. A., Greene, T., Kuhlmann, M. K., Levin, N. W., & Rocco, M. V. (2008). Surface-Area-Normalized Kt/V: A Method of Rescaling Dialysis Dose to Body Surface Area-Implications for Different-Size Patients by Gender. SEMINARS IN DIALYSIS, 21(5), 415-421.
  
• A comparison of change in measured and estimated glomerular filtration rate in patients with nondiabetic kidney disease Xie, D., Joffe, M. M., Brunelli, S. M., Beck, G., Chertow, G. M., & Feldman, H. I. (2008). A comparison of change in measured and estimated glomerular filtration rate in patients with nondiabetic kidney disease. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 3(5), 1332-1338.
  
• Comparison of Proposed Alternative Methods for Rescaling Dialysis Close: Resting Energy Expenditure, High Metabolic Rate Organ Mass, Liver Size, and Body Surface Area Daugirdas, J. T., Levin, N. W., Kotanko, P., Depner, T. A., Kuhlmann, M. K., & Rocco, M. V. (2008). Comparison of Proposed Alternative Methods for Rescaling Dialysis Close: Resting Energy Expenditure, High Metabolic Rate Organ Mass, Liver Size, and Body Surface Area. SEMINARS IN DIALYSIS, 21(5), 377-384.
  
• Cost-effectiveness of frequent in-center hemodialysis Lee, C. P., Zenios, S. A., & Chertow, G. M. (2008). Cost-effectiveness of frequent in-center hemodialysis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 19(9), 1792-1797.
  
• Intensity of renal support in critically ill patients with acute kidney injury Palevsky, P. M., Zhang, J. H., O'Connor, T. Z., Chertow, G. M., Crowley, S. T., & Peduzzi, P. (2008). Intensity of renal support in critically ill patients with acute kidney injury. NEW ENGLAND JOURNAL OF MEDICINE, 359(1), 7-20.
  
• Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism Block, G. A., Zeig, S., Sugihara, J., Chertow, G. M., Chi, E. M., & Bushinsky, D. A. (2008). Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism. NEPHROLOGY DIALYSIS TRANSPLANTATION, 23(7), 2311-2318.
  
• Lessons for successful study enrollment from the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Study Crowley, S. T., Chertow, G. M., Vitale, J., O'Connor, T., Zhang, J., & Palevsky, P. M. (2008). Lessons for successful study enrollment from the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Study. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 3(4), 955-961.
  
• Higher serum creatinine concentrations in black patients with chronic kidney disease: Beyond nutritional status and body composition Hsu, J., Johansen, K. L., Hsu, C.-Y., Kaysen, G. A., & Chertow, G. M. (2008). Higher serum creatinine concentrations in black patients with chronic kidney disease: Beyond nutritional status and body composition. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 3(4), 992-997.
  
• The risk of acute renal failure in patients with chronic kidney disease Hsu, C. Y., Ordonez, J. D., Chertow, G. M., Fan, D., McCulloch, C. E., & Go, A. S. (2008). The risk of acute renal failure in patients with chronic kidney disease. KIDNEY INTERNATIONAL, 74(1), 101-107.
  
• Trends and outcomes associated with serum albumin concentration among incident dialysis patients in the United States Kaysen, G. A., Johansen, K. L., Cheng, S.-C., Jin, C., & Chertow, G. M. (2008). Trends and outcomes associated with serum albumin concentration among incident dialysis patients in the United States. JOURNAL OF RENAL NUTRITION, 18(4), 323-331.
  
• Diagnosis, epidemiology and outcomes of acute kidney injury Waikar, S. S., Liu, K. D., & Chertow, G. M. (2008). Diagnosis, epidemiology and outcomes of acute kidney injury. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 3(3), 844-861.
  
• Toward the promise of renal replacement therapy Chertow, G. M., & Waikar, S. S. (2008). Toward the promise of renal replacement therapy. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 19(5), 839-840.
  
• High-molecular weight iron dextran: A wolf in sheep's clothing? Rodgers, G. M., Auerbach, M., Cella, D., Chertow, G. M., Coyne, D. W., & Henry, D. H. (2008). High-molecular weight iron dextran: A wolf in sheep's clothing?. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 19(5), 833-834.
  
• Kidney dysfunction and fatal cardiovascular disease - an association independent of atherosclerotic events: Results from the Health, Aging, and Body Composition (Health ABC) study Deo, R., Fyr, C. Lw., Fried, L. F., Newman, A. B., Harris, T. B., & Shlipak, M. G. (2008). Kidney dysfunction and fatal cardiovascular disease - an association independent of atherosclerotic events: Results from the Health, Aging, and Body Composition (Health ABC) study. AMERICAN HEART JOURNAL, 155(1), 62-68.
  
• Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury Liu, K. D., Glidden, D. V., Eisner, M. D., Parsons, P. E., Ware, L. B., & Matthay, M. A. (2007). Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury. CRITICAL CARE MEDICINE, 35(12), 2755-2761.
  
• Significance of frailty among dialysis patients Johansen, K. L., Chertow, G. M., Jin, C., & Kutner, N. G. (2007). Significance of frailty among dialysis patients. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 18(11), 2960-2967.
  
• Kidney function as a predictor of loss of lean mass in older adults: Health, aging and body composition study Fried, L. F., Boudreau, R., Lee, J. S., Chertow, G., Kurella-Tamura, M., & Newman, A. B. (2007). Kidney function as a predictor of loss of lean mass in older adults: Health, aging and body composition study. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 55(10), 1578-1584.
  
• Race and mortality after acute renal failure Waikar, S. S., Curhan, G. C., Ayanian, J. Z., & Chertow, G. M. (2007). Race and mortality after acute renal failure. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 18(10), 2740-2748.
  
• Chronic kidney disease mineral bone disorder and health-related quality of life among incident end-stage renal-disease patients Johansen, K. L., & Chertow, G. M. (2007). Chronic kidney disease mineral bone disorder and health-related quality of life among incident end-stage renal-disease patients. JOURNAL OF RENAL NUTRITION, 17(5), 305-313.
  
• Evaluation of cinacalcet therapy to lower cardiovascular events (EVOLVE): Rationale and design overview Chertow, G. M., Pupim, L. B., Block, G. A., Correa-Rotter, R., Drueke, T. B., & Parfrey, P. (2007). Evaluation of cinacalcet therapy to lower cardiovascular events (EVOLVE): Rationale and design overview. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2(5), 898-905.
  
• Rise of pay for performance: Implications for care of people with chronic kidney disease Desai, A. A., Garber, A. M., & Chertow, G. M. (2007). Rise of pay for performance: Implications for care of people with chronic kidney disease. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2(5), 1087-1095.
  
• Community-based incidence of acute renal failure Hsu, C.- y, McCulloch, C. E., Fan, D., Ordonez, J. D., Chertow, G. M., & Go, A. S. (2007). Community-based incidence of acute renal failure. KIDNEY INTERNATIONAL, 72(2), 208-212.
  
• Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease - Data from the heart and soul study Ix, J. H., Chertow, G. M., Shlipak, M. G., Brandenburg, V. M., Ketteler, M., & Whooley, M. A. (2007). Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease - Data from the heart and soul study. CIRCULATION, 115(19), 2533-2539.
  
• The incidence and prognostic significance of acute kidney injury Waikar, S. S., Liu, K. D., & Chertow, G. M. (2007). The incidence and prognostic significance of acute kidney injury. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 16(3), 227-236.
  
• Octogenarians and nonagenarians starting dialysis in the United States Kurella, M., Covinsky, K. E., Collins, A. J., & Chertow, G. M. (2007). Octogenarians and nonagenarians starting dialysis in the United States. ANNALS OF INTERNAL MEDICINE, 146(3), 177-183.
  
• Frequent Hemodialysis Network (FHN) randomized trials: Study design Suri, R. S., Garg, A. X., Chertow, G. M., Levin, N. W., Rocco, M. V., & Kliger, A. S. (2007). Frequent Hemodialysis Network (FHN) randomized trials: Study design. KIDNEY INTERNATIONAL, 71(4), 349-359.
  
• Phosphorus balance and mineral metabolism with 3 h daily hemodialysis Ayus, J. C., Achinger, S. G., Mizani, M. R., Chertow, G. M., Furmaga, W., & Rodriguez, F. (2007). Phosphorus balance and mineral metabolism with 3 h daily hemodialysis. KIDNEY INTERNATIONAL, 71(4), 336-342.
  
• Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease - Data from the Heart and Soul Study Ix, J. H., Shlipak, M. G., Chertow, G. M., & Whooley, M. A. (2007). Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease - Data from the Heart and Soul Study. CIRCULATION, 115(2), 173-179.
  
• End stage renal disease. Hall, Y. N., & Chertow, G. M. (2007). End stage renal disease. Clinical evidence.
  
• Cystatin C and measures of physical function in elderly adults - The health, aging, and body composition (HABC) study Odden, M. C., Chertow, G. M., Fried, L. F., Newman, A. B., Connelly, S., & Shlipak, M. G. (2006). Cystatin C and measures of physical function in elderly adults - The health, aging, and body composition (HABC) study. AMERICAN JOURNAL OF EPIDEMIOLOGY, 164(12), 1180-1189.
  
• Less-than-subtotal parathyroidectomy increases the risk of persistent/recurrent hyperparathyroidism after parathyroidectomy in tertiary hyperparathyroidism after renal transplantation Triponez, F., Kebebew, E., Dosseh, D., Duh, Q.-Y., Hazzan, M., & Clark, O. H. (2006). Less-than-subtotal parathyroidectomy increases the risk of persistent/recurrent hyperparathyroidism after parathyroidectomy in tertiary hyperparathyroidism after renal transplantation. SURGERY, 140(6), 990-997.
  
• Survival by dialysis modality in critically ill patients with acute kidney injury Cho, K. C., Himmelfarb, J., Paganini, E., Ikizler, T. A., Soroko, S. H., & Chertow, G. M. (2006). Survival by dialysis modality in critically ill patients with acute kidney injury. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 17(11), 3132-3138.
  
• Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease Peralta, C. A., Shlipak, M. G., Fan, D., Ordonez, J., Lash, J. P., & Go, A. S. (2006). Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 17(10), 2892-2899.
  
• Tesio catheter access for long-term maintenance hemodialysis Wang, J., LaBerge, J. M., Chertow, G. M., Kerlan, R. K., Wilson, M. W., & Gordon, R. L. (2006). Tesio catheter access for long-term maintenance hemodialysis. RADIOLOGY, 241(1), 284-290.
  
• Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: Data from The Heart and Soul Study Ix, J. H., Shlipak, M. G., Chertow, G. M., Ali, S., Schiller, N. B., & Whooley, M. A. (2006). Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: Data from The Heart and Soul Study. JOURNAL OF CARDIAC FAILURE, 12(8), 601-607.
  
• Studying the prevention of acute kidney injury: Lessons from an 18th-century mathematician Chertow, G. M., Palevsky, P. M., & Greene, T. (2006). Studying the prevention of acute kidney injury: Lessons from an 18th-century mathematician. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1(5), 1124-1127.
  
• A simulation model to estimate the cost and effectiveness of alternative dialysis initiation strategies Lee, C. P., Chertow, G. M., & Zenios, S. A. (2006). A simulation model to estimate the cost and effectiveness of alternative dialysis initiation strategies. MEDICAL DECISION MAKING, 26(5), 535-549.
  
• Timing of initiation of dialysis in critically ill patients with acute kidney injury Liu, K. D., Himmelfarb, J., Paganini, E., Ikizler, T. A., Soroko, S. H., & Chertow, G. M. (2006). Timing of initiation of dialysis in critically ill patients with acute kidney injury. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1(5), 915-919.
  
• Mortality after acute renal failure: Models for prognostic stratification and risk adjustment Chertow, G. M., Soroko, S. H., Paganini, E. P., Cho, K. C., Himmelfarb, J., & Mehta, R. L. (2006). Mortality after acute renal failure: Models for prognostic stratification and risk adjustment. KIDNEY INTERNATIONAL, 70(6), 1120-1126.
  
• Correlates and outcomes of dementia among dialysis patients: the Dialysis Outcomes and Practice Patterns Study Kurella, M., Mapes, D. L., Port, F. K., & Chertow, G. M. (2006). Correlates and outcomes of dementia among dialysis patients: the Dialysis Outcomes and Practice Patterns Study. NEPHROLOGY DIALYSIS TRANSPLANTATION, 21(9), 2543-2548.
  
• Fetuin-A and kidney function in persons with coronary artery disease-data from the heart and soul study Ix, J. H., Chertow, G. M., Shlipak, M. G., Brandenburg, V. M., Ketteler, M., & Whooley, M. A. (2006). Fetuin-A and kidney function in persons with coronary artery disease-data from the heart and soul study. NEPHROLOGY DIALYSIS TRANSPLANTATION, 21(8), 2144-2151.
  
• Renal function and heart failure risk in older black and white individuals - The health, aging, and body composition study Bibbins-Domingo, K., Chertow, G. M., Fried, L. F., Odden, M. C., Newman, A. B., & Shlipak, M. G. (2006). Renal function and heart failure risk in older black and white individuals - The health, aging, and body composition study. ARCHIVES OF INTERNAL MEDICINE, 166(13), 1396-1402.
  
• The metabolic syndrome and chronic kidney disease Peralta, C. A., Kurella, M., Lo, J. C., & Chertow, G. M. (2006). The metabolic syndrome and chronic kidney disease. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 15(4), 361-365.
  
• The tortoise and hare on hemodialysis: Does slow and steady win the race? Chertow, G. M., Kurella, M., & Lowrie, E. G. (2006). The tortoise and hare on hemodialysis: Does slow and steady win the race?. KIDNEY INTERNATIONAL, 70(1), 24-25.
  
• The case against calcium-based phosphate binders Moe, S. M., & Chertow, G. M. (2006). The case against calcium-based phosphate binders. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1(4), 697-703.
  
• Evolving practices in critical care and potential implications for management of acute kidney injury Liu, K. D., Matthay, M. A., & Chertow, G. M. (2006). Evolving practices in critical care and potential implications for management of acute kidney injury. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1(4), 869-873.
  
• Guidelines for disorders of mineral metabolism and secondary hyperparathyroidism should not yet be modified Ix, J. H., Quarles, L. D., & Chertow, G. M. (2006). Guidelines for disorders of mineral metabolism and secondary hyperparathyroidism should not yet be modified. NATURE CLINICAL PRACTICE NEPHROLOGY, 2(6), 337-339.
  
• The enlarging body of evidence: Obesity and chronic kidney disease Chertow, G. M., Hsu, C.-Y., & Johansen, K. L. (2006). The enlarging body of evidence: Obesity and chronic kidney disease. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 17(6), 1501-1502.
  
• Validity of International Classification of Diseases, Ninth Revision, Clinical Modification codes for acute renal failure Waikar, S. S., Wald, R., Chertow, G. M., Curhan, G. C., Winkelmayer, W. C., & Jaber, B. L. (2006). Validity of International Classification of Diseases, Ninth Revision, Clinical Modification codes for acute renal failure. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 17(6), 1688-1694.
  
• End stage renal disease. Hall, Y. N., & Chertow, G. M. (2006). End stage renal disease. Clinical evidence, (15), 1171-1181.
  
• Declining mortality in patients with acute renal failure, 1988 to 2002 Waikar, S. S., Curhan, G. C., Wald, R., McCarthy, E. P., & Chertow, G. M. (2006). Declining mortality in patients with acute renal failure, 1988 to 2002. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 17(4), 1143-1150.
  
• Association of body size with health status in patients beginning dialysis Johansen, K. L., Kutner, N. G., Young, B., & Chertow, G. M. (2006). Association of body size with health status in patients beginning dialysis. AMERICAN JOURNAL OF CLINICAL NUTRITION, 83(3), 543-549.
  
• Strategies for successful patient oriented research: Why did I (not) get funded? Agarwal, R., Chertow, G. M., & Mehta, R. L. (2006). Strategies for successful patient oriented research: Why did I (not) get funded?. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1(2), 340-343.
  
• Cinacalcet hydrochloride (sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate Chertow, G. M., Blumenthal, S., Turner, S., Roppolo, M., Stern, L., & Reed, J. (2006). Cinacalcet hydrochloride (sensipar) in hemodialysis patients on active vitamin D derivatives with controlled PTH and elevated calcium x phosphate. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1(2), 305-312.
  
• Acute renal failure after endovascular vs open repair of abdominal aortic aneurysm Wald, R., Waikar, S. S., Liangos, O., Pereira, B. Jg., Chertow, G. M., & Jaber, B. L. (2006). Acute renal failure after endovascular vs open repair of abdominal aortic aneurysm. JOURNAL OF VASCULAR SURGERY, 43(3), 460-466.
  
• Update on adverse drug events associated with parenteral iron Chertow, G. M., Mason, P. D., Vaage-Nilsen, O., & Ahlmen, J. (2006). Update on adverse drug events associated with parenteral iron. NEPHROLOGY DIALYSIS TRANSPLANTATION, 21(2), 378-382.
  
• Challenging the validity of the EPO index. Kaysen, G. A., Müller, H. G., Ding, J., & Chertow, G. M. (2006). Challenging the validity of the EPO index. American journal of kidney diseases , 47(1), 166-?.
  
• Challenging the validity of the EPO index Kaysen, G. A., Muller, H. G., Ding, J., & Chertow, G. M. (2006). Challenging the validity of the EPO index. AMERICAN JOURNAL OF KIDNEY DISEASES, 47(1), 157-166.
  
• Cystatin C and mortality risk in the elderly: The health, aging, and body composition study Shlipak, M. G., Fyr, C. Lw., Chertow, G. M., Harris, T. B., Kritchevsky, S. B., & Fried, L. F. (2006). Cystatin C and mortality risk in the elderly: The health, aging, and body composition study. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 17(1), 254-261.
  
• PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis Danese, M. D., Kim, J., Doan, Q. V., Dylan, M., Griffiths, R., & Chertow, G. M. (2006). PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis. AMERICAN JOURNAL OF KIDNEY DISEASES, 47(1), 149-156.
  
• Lessons for Medicare Part D in the hemodialysis community. Nayeem, A. I., & Chertow, G. M. (2006). Lessons for Medicare Part D in the hemodialysis community. BMC nephrology, 7, 11-?.
  
• Health-related quality of life and estimates of utility in chronic kidney disease Gorodetskaya, I., Zenios, S., McCulloch, C. E., Bostrom, A., Hsu, C. Y., & Chertow, G. M. (2005). Health-related quality of life and estimates of utility in chronic kidney disease. KIDNEY INTERNATIONAL, 68(6), 2801-2808.
  
• Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients Chertow, G. M., Goldstein-Fuchs, D. J., Lazarus, J. M., & Kaysen, G. A. (2005). Prealbumin, mortality, and cause-specific hospitalization in hemodialysis patients. KIDNEY INTERNATIONAL, 68(6), 2794-2800.
  
• Self-reported appetite, hospitalization and death in haemodialysis patients: findings from the hemodialysis (HEMO) study Burrowes, J. D., Larive, B., Chertow, G. M., Cockram, D. B., Dwyer, J. T., & Rocco, M. V. (2005). Self-reported appetite, hospitalization and death in haemodialysis patients: findings from the hemodialysis (HEMO) study. NEPHROLOGY DIALYSIS TRANSPLANTATION, 20(12), 2765-2774.
  
• Differential mortality and transplantation rates among Asians and Pacific Islanders with ESRD Hall, Y. N., Sugihara, J. G., Go, A. S., & Chertow, G. M. (2005). Differential mortality and transplantation rates among Asians and Pacific Islanders with ESRD. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(12), 3711-3720.
  
• Acute kidney injury, mortality, length of stay, and costs in hospitalized patients Chertow, G. M., Burdick, E., Honour, M., Bonventre, J. V., & Bates, D. W. (2005). Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(11), 3365-3370.
  
• Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism Cunningham, J., Danese, M., Olson, K., Klassen, P., & Chertow, G. M. (2005). Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. KIDNEY INTERNATIONAL, 68(4), 1793-1800.
  
• Are nutritional status indicators associated with mortality in the Hemodialysis (HEMO) Study ? Dwyer, J. T., Larive, B., Leung, J., Rocco, M. V., Greene, T., & Kusek, J. W. (2005). Are nutritional status indicators associated with mortality in the Hemodialysis (HEMO) Study ?. KIDNEY INTERNATIONAL, 68(4), 1766-1776.
  
• Insulin resistance in critically ill patients with acute renal failure Basi, S., Pupim, L. B., Simmons, E. M., Sezer, M. T., Shyr, Y., & Ikizler, T. A. (2005). Insulin resistance in critically ill patients with acute renal failure. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 289(2), F259-F264.
  
• Chronic kidney disease and cognitive impairment in the elderly: The health, aging, and body composition study Kurella, M., Chertow, G. M., Fried, L. F., Cummings, S. R., Harris, T., & Yaffe, K. (2005). Chronic kidney disease and cognitive impairment in the elderly: The health, aging, and body composition study. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(7), 2127-2133.
  
• Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults Kurella, M., Lo, J. C., & Chertow, G. M. (2005). Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(7), 2134-2140.
  
• Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates Kirtane, A. J., Leder, D. M., Waikar, S. S., Chertow, G. M., Ray, K. K., & Gibson, C. M. (2005). Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 45(11), 1781-1786.
  
• Control of hypertension in adults with chronic kidney disease in the United States Peralta, C. A., Hicks, L. S., Chertow, G. M., Ayanian, J. Z., Vittinghoff, E., & Shlipak, M. G. (2005). Control of hypertension in adults with chronic kidney disease in the United States. HYPERTENSION, 45(6), 1119-1124.
  
• Beyond Framingham: Cardiovascular risk profiling in ESRD McClellan, W. M., & Chertow, G. M. (2005). Beyond Framingham: Cardiovascular risk profiling in ESRD. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(6), 1539-1541.
  
• End stage renal disease. Hall, Y., & Chertow, G. (2005). End stage renal disease. Clinical evidence, (13), 1048-1059.
  
• Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients Ferramosca, E., Burke, S., Chasan-Taber, S., Ratti, C., Chertow, G. M., & Raggi, P. (2005). Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients. AMERICAN HEART JOURNAL, 149(5), 820-825.
  
• Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis Raggi, P., James, G., Burke, S. K., Bommer, J., Chasan-Taber, S., & Chertow, G. M. (2005). Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis. JOURNAL OF BONE AND MINERAL RESEARCH, 20(5), 764-772.
  
• Medicare ESRD prospective payment system: Weighing the evidence Himmelfarb, J., & Chertow, G. M. (2005). Medicare ESRD prospective payment system: Weighing the evidence. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(5), 1164-1165.
  
• Bone disease and bottle caps Tichy, M., Garg, J. P., Cho, K. C., & Chertow, G. M. (2005). Bone disease and bottle caps. JOURNAL OF RENAL NUTRITION, 15(2), 257-259.
  
• Frequent hemodialysis and psychosocial function Kurella, M., Suri, R. S., & Chertow, G. M. (2005). Frequent hemodialysis and psychosocial function. SEMINARS IN DIALYSIS, 18(2), 132-136.
  
• Suicide in the United States end-stage renal disease program Kurella, M., Kimmel, P. L., Young, B. S., & Chertow, G. M. (2005). Suicide in the United States end-stage renal disease program. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(3), 774-781.
  
• Dialysis session length ("t") as a determinant of the adequacy of dialysis Kurella, M., & Chertow, G. M. (2005). Dialysis session length ("t") as a determinant of the adequacy of dialysis. SEMINARS IN NEPHROLOGY, 25(2), 90-95.
  
• Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease Lo, J. C., Chertow, G. M., Go, A. S., & Hsu, C. Y. (2005). Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. KIDNEY INTERNATIONAL, 67(3), 1047-1052.
  
• Achieving NKF-K/DOQI (TM) bone metabolism and disease treatment goals with cinacalcet HCl Moe, S. M., Chertow, G. M., Coburn, J. W., Quarles, L. D., Goodman, W. G., & Martin, K. J. (2005). Achieving NKF-K/DOQI (TM) bone metabolism and disease treatment goals with cinacalcet HCl. KIDNEY INTERNATIONAL, 67(2), 760-771.
  
• Calcification or classification? Chertow, G. M., & Moe, S. M. (2005). Calcification or classification?. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(2), 293-295.
  
• Self-assessed sleep quality in chronic kidney disease. Kurella, M., Luan, J., Lash, J. P., & Chertow, G. M. (2005). Self-assessed sleep quality in chronic kidney disease. International urology and nephrology, 37(1), 159-165.
  
• Influence of race on kidney transplant outcomes within and outside the department of veterans affairs Chakkera, H. A., O'Hare, A. M., Johansen, K. L., Hynes, D., Stroupe, K., & Chertow, G. M. (2005). Influence of race on kidney transplant outcomes within and outside the department of veterans affairs. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 16(1), 269-277.
  
• Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis - A randomized clinical trial Garg, J. P., Chasan-Taber, S., Blair, A., Plone, M., Bommer, J., & Chertow, G. M. (2005). Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis - A randomized clinical trial. ARTHRITIS AND RHEUMATISM, 52(1), 290-295.
  
• Angiotensin receptor blockade and arterial compliance in chronic kidney disease: A pilot study Garg, J. P., Ellis, R., Elliott, W. J., Hasabou, N., Chua, D., & Bakris, G. L. (2005). Angiotensin receptor blockade and arterial compliance in chronic kidney disease: A pilot study. AMERICAN JOURNAL OF NEPHROLOGY, 25(4), 393-399.
  
• Chronic kidney disease and cognitive impairment in menopausal women Kurella, M., Yaffe, K., Shlipak, M. G., Wenger, N. K., & Chertow, G. M. (2005). Chronic kidney disease and cognitive impairment in menopausal women. AMERICAN JOURNAL OF KIDNEY DISEASES, 45(1), 66-76.
  
• Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction - The Survival and Ventricular Enlargement (SAVE) study Tokmakova, M. P., Skali, H., Kenchaiah, S., Braunwald, E., Rouleau, J. L., & Solomon, S. D. (2004). Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction - The Survival and Ventricular Enlargement (SAVE) study. CIRCULATION, 110(24), 3667-3673.
  
• Validation of the kidney disease quality of life (KDQOL) cognitive function subscale Kurella, M., Luan, J., Yaffe, K., & Chertow, G. M. (2004). Validation of the kidney disease quality of life (KDQOL) cognitive function subscale. KIDNEY INTERNATIONAL, 66(6), 2361-2367.
  
• Cognitive impairment in chronic kidney disease Kurella, M., Chertow, G. M., Luan, J., & Yaffe, K. (2004). Cognitive impairment in chronic kidney disease. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 52(11), 1863-1869.
  
• Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis Ix, J. H., McCulloch, C. E., & Chertow, G. M. (2004). Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis. NEPHROLOGY DIALYSIS TRANSPLANTATION, 19(11), 2747-2753.
  
• Spectrum of acute renal failure in the intensive care unit: The PICARD experience Mehta, R. L., Pascual, M. T., Soroko, S., Savage, B. R., Himmelfarb, J., & Chertow, G. M. (2004). Spectrum of acute renal failure in the intensive care unit: The PICARD experience. KIDNEY INTERNATIONAL, 66(4), 1613-1621.
  
• Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization Go, A. S., Chertow, G. M., Fan, D. J., McCulloch, C. E., & Hsu, C. Y. (2004). Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. NEW ENGLAND JOURNAL OF MEDICINE, 351(13), 1296-1305.
  
• Race/ethnicity and disease severity in IgA nephropathy. Hall, Y. N., Fuentes, E. F., Chertow, G. M., & Olson, J. L. (2004). Race/ethnicity and disease severity in IgA nephropathy. BMC nephrology, 5, 10-?.
  
• Diminishing significance of HLA matching in kidney transplantation Su, X. M., Zenios, S. A., Chakkera, H., Milford, E. L., & Chertow, G. M. (2004). Diminishing significance of HLA matching in kidney transplantation. AMERICAN JOURNAL OF TRANSPLANTATION, 4(9), 1501-1508.
  
• Vector length as a proxy for the adequacy of ultrafiltration in hemodialysis Pillon, L., Piccoli, A., Lowrie, E. G., Lazarus, J. M., & Chertow, G. M. (2004). Vector length as a proxy for the adequacy of ultrafiltration in hemodialysis. KIDNEY INTERNATIONAL, 66(3), 1266-1271.
  
• "Renalism": Inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency Chertow, G. M., Normand, S. Lt., & McNeil, B. J. (2004). "Renalism": Inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 15(9), 2462-2468.
  
• Mineral metabolism, mortality, and morbidity in maintenance hemodialysis Block, G. A., Klassen, P. S., Lazarus, J. M., Ofsthun, N., Lowrie, E. G., & Chertow, G. M. (2004). Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 15(8), 2208-2218.
  
• Association of body size with outcomes among patients beginning dialysis Johansen, K. L., Young, B., Kaysen, G. A., & Chertow, G. M. (2004). Association of body size with outcomes among patients beginning dialysis. AMERICAN JOURNAL OF CLINICAL NUTRITION, 80(2), 324-332.
  
• Coronary and aortic calcifications in patients new to dialysis. Spiegel, D. M., Raggi, P., Mehta, R., Lindberg, J. S., Chonchol, M., & Block, G. A. (2004). Coronary and aortic calcifications in patients new to dialysis. Hemodialysis international. International Symposium on Home Hemodialysis, 8(3), 265-272.
  
• Incorporating recipient choice in kidney transplantation Su, X. M., Zenios, S. A., & Chertow, G. M. (2004). Incorporating recipient choice in kidney transplantation. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 15(6), 1656-1663.
  
• On the relative safety of parenteral iron formulations Chertow, G. M., Mason, P. D., Vaage-Nilsen, O., & Ahlmen, J. (2004). On the relative safety of parenteral iron formulations. NEPHROLOGY DIALYSIS TRANSPLANTATION, 19(6), 1571-1575.
  
• Determinants of progressive vascular calcification in haemodialysis patients Chertow, G. M., Raggi, P., Chasan-Taber, S., Bommer, J., Holzer, H., & Burke, S. K. (2004). Determinants of progressive vascular calcification in haemodialysis patients. NEPHROLOGY DIALYSIS TRANSPLANTATION, 19(6), 1489-1496.
  
• Prevention of radiocontrast nephropathy - Back to basics Chertow, G. M. (2004). Prevention of radiocontrast nephropathy - Back to basics. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 291(19), 2376-2377.
  
• Screening to prevent coronary events or screening to detect obstruction? Raggi, P., Budoff, M. J., & Chertow, G. M. (2004). Screening to prevent coronary events or screening to detect obstruction?. AMERICAN JOURNAL OF KIDNEY DISEASES, 43(5), 940-940.
  
• Physical and sexual function in women with chronic kidney disease Kurella, M., Ireland, C., Hlatky, M. A., Shlipak, M. G., Yaffe, K., & Chertow, G. M. (2004). Physical and sexual function in women with chronic kidney disease. AMERICAN JOURNAL OF KIDNEY DISEASES, 43(5), 868-876.
  
• The influence of patient- and facility-specific factors on nutritional status and survival in hemodialysis Kaysen, G. A., Muller, H. G., Young, B. S., Leng, X. Y., & Chertow, G. M. (2004). The influence of patient- and facility-specific factors on nutritional status and survival in hemodialysis. JOURNAL OF RENAL NUTRITION, 14(2), 72-81.
  
• Plasma cytokine levels predict mortality in patients with acute renal failure Simmons, E. M., Himmelfarb, J., Sezer, M. T., Chertow, G. M., Mehta, R. L., & Ikizler, T. A. (2004). Plasma cytokine levels predict mortality in patients with acute renal failure. KIDNEY INTERNATIONAL, 65(4), 1357-1365.
  
• A 43-year-old woman with chronic renal insufficiency Chertow, G. M. (2004). A 43-year-old woman with chronic renal insufficiency. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 291(10), 1252-1259.
  
• Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus, binders or sevelamer Raggi, P., Bommer, J., & Chertow, G. M. (2004). Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus, binders or sevelamer. JOURNAL OF HEART VALVE DISEASE, 13(1), 134-141.
  
• Multi-attribute utility and health-related quality of life in persons with CKD stages IV-V. Gorodetskaya, I., Young, B. S., Hsu, C. Y., Zenios, S. A., & Chertow, G. M. (2003). Multi-attribute utility and health-related quality of life in persons with CKD stages IV-V. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 14, 810A-810A.
  
• Slowing the progression of vascular calcification in hemodialysis Chertow, G. M. (2003). Slowing the progression of vascular calcification in hemodialysis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 14(9), S310-S314.
  
• Anthropometrically estimated total body water volumes are larger than modeled urea volume in chronic hemodialysis patients: Effects of age, race, and gender Daugirdas, J. T., Greene, T., Depner, T. A., Chumlea, C., Rocco, M. J., & Chertow, G. M. (2003). Anthropometrically estimated total body water volumes are larger than modeled urea volume in chronic hemodialysis patients: Effects of age, race, and gender. KIDNEY INTERNATIONAL, 64(3), 1108-1119.
  
• Reasons for non-enrollment in a cohort study of ARF: The program to improve care in acute renal disease (PICARD) experience and implications for a clinical trials network Chertow, G. M., Pascual, M. T., Soroko, S., Savage, B. R., Himmelfarb, J., & Mehta, R. L. (2003). Reasons for non-enrollment in a cohort study of ARF: The program to improve care in acute renal disease (PICARD) experience and implications for a clinical trials network. AMERICAN JOURNAL OF KIDNEY DISEASES, 42(3), 507-512.
  
• The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients Chertow, G. M., Raggi, P., McCarthy, J. T., Schulman, G., Silberzweig, J., & Toto, R. D. (2003). The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients. AMERICAN JOURNAL OF NEPHROLOGY, 23(5), 307-314.
  
• Acute renal failure definitions and classification: Time for change? Mehta, R. L., & Chertow, G. M. (2003). Acute renal failure definitions and classification: Time for change?. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 14(8), 2178-2187.
  
• Analgesia in patients with ESRD: A review of available evidence Kurella, M., Bennett, W. M., & Chertow, G. M. (2003). Analgesia in patients with ESRD: A review of available evidence. AMERICAN JOURNAL OF KIDNEY DISEASES, 42(2), 217-228.
  
• Inflammatory markers are unrelated to physical activity, performance, and functioning in hemodialysis Hung, A. M., Chertow, G. A., Young, B. S., Carey, S., & Johansen, K. L. (2003). Inflammatory markers are unrelated to physical activity, performance, and functioning in hemodialysis. ADVANCES IN RENAL REPLACEMENT THERAPY, 10(3), 232-240.
  
• The Chronic Renal Insufficiency Cohort (CRIC) study: Design and methods Feldman, H. I., Appel, L. J., Chertow, G. M., Cifelli, D., Cizman, B., & Wright, J. T. (2003). The Chronic Renal Insufficiency Cohort (CRIC) study: Design and methods. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 14(7), S148-S153.
  
• Longitudinal study of nutritional status, body composition, and physical function in hemodialysis patients Johansen, K. L., Kaysen, G. A., Young, B. S., Hung, A. M., Da Silva, M., & Chertow, G. M. (2003). Longitudinal study of nutritional status, body composition, and physical function in hemodialysis patients. AMERICAN JOURNAL OF CLINICAL NUTRITION, 77(4), 842-846.
  
• Beware the rising creatinine level Shlipak, M. G., Chertow, G. C., & Massie, B. M. (2003). Beware the rising creatinine level. JOURNAL OF CARDIAC FAILURE, 9(1), 26-28.
  
• In critically ill patients with acute renal failure, outcomes, not dollars, should drive modality choice Mehta, R. L., & Chertow, G. M. (2003). In critically ill patients with acute renal failure, outcomes, not dollars, should drive modality choice. CRITICAL CARE MEDICINE, 31(2), 644-646.
  
• The decline in residual renal function in hemodialysis is slow and age dependent. Hung, A. M., Young, B. S., & Chertow, G. M. (2003). The decline in residual renal function in hemodialysis is slow and age dependent. Hemodialysis international. International Symposium on Home Hemodialysis, 7(1), 17-22.
  
• Diuretics, mortality, and nonrecovery of renal function in acute renal Mehta, R. L., Pascual, M. T., Soroko, S., & Chertow, G. M. (2002). Diuretics, mortality, and nonrecovery of renal function in acute renal. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 288(20), 2547-2553.
  
• The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease de Boer, I. H., Gorodetskaya, I., Young, B., Hsu, C. Y., & Chertow, G. M. (2002). The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 13(11), 2762-2769.
  
• Nephrology consultation in acute renal failure: Does timing matter? Mehta, R. L., McDonald, B., Gabbai, F., Pahl, M., Farkas, A., & Chertow, G. M. (2002). Nephrology consultation in acute renal failure: Does timing matter?. AMERICAN JOURNAL OF MEDICINE, 113(6), 456-461.
  
• Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients Shlipak, M. G., Heidenreich, P. A., Noguchi, H., Chertow, G. M., Browner, W. S., & McClellan, M. B. (2002). Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. ANNALS OF INTERNAL MEDICINE, 137(7), 555-562.
  
• Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency Hsu, C. Y., & Chertow, G. M. (2002). Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency. NEPHROLOGY DIALYSIS TRANSPLANTATION, 17(8), 1419-1425.
  
• Inflammatory markers are unrelated to physical activity, performance, and functioning in hemodialysis Hung, A. M., Chertow, G. M., Young, B. S., Carey, S., & Johansen, K. L. (2002). Inflammatory markers are unrelated to physical activity, performance, and functioning in hemodialysis. JOURNAL OF RENAL NUTRITION, 12(3), 170-176.
  
• Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients Chertow, G. M., Burke, S. K., & Raggi, P. (2002). Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. KIDNEY INTERNATIONAL, 62(1), 245-252.
  
• Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency Hsu, C. Y., Chertow, G. M., & Curhan, G. C. (2002). Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. KIDNEY INTERNATIONAL, 61(5), 1567-1576.
  
• Refining predictive models in critically ill patients with acute renal failure Mehta, R. L., Pascual, M. T., Gruta, C. G., Zhuang, S. P., & Chertow, G. M. (2002). Refining predictive models in critically ill patients with acute renal failure. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 13(5).
  
• Bone mineral density is not diminished by mild to moderate chronic renal insufficiency Hsu, C. Y., Cummings, S. R., McCulloch, C. E., & Chertow, G. A. (2002). Bone mineral density is not diminished by mild to moderate chronic renal insufficiency. KIDNEY INTERNATIONAL, 61(5), 1814-1820.
  
• With bioimpedance spectroscopy, the errors get fat when the patients get slim Chertow, G. M. (2002). With bioimpedance spectroscopy, the errors get fat when the patients get slim. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 26(2), 128-129.
  
• Cardiac calcification in adult Hemodialysis patients - A link between end-stage renal disease and cardiovascular disease? Raggi, P., Boulay, A., Chasan-Taber, S., Amin, N., Dillon, M., & Chertow, G. M. (2002). Cardiac calcification in adult Hemodialysis patients - A link between end-stage renal disease and cardiovascular disease?. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 39(4), 695-701.
  
• Renal insufficiency with monoclonal gammopathy and urticarial vasculitis O''Hare, A., Olson, J. L., Connolly, M. K., Ward, J. W., Stein, P., & Chertow, G. M. (2002). Renal insufficiency with monoclonal gammopathy and urticarial vasculitis. AMERICAN JOURNAL OF KIDNEY DISEASES, 39(1), 203-207.
  
• Guided medication dosing for inpatients with renal insufficiency Chertow, G. M., Lee, J., Kuperman, G. J., Burdick, E., Horsky, J., & Bates, D. W. (2001). Guided medication dosing for inpatients with renal insufficiency. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 286(22), 2839-2844.
  
• "Wishing don't make it so" - Why we need a randomized clinical trial of high-intensity hemodialysis Chertow, G. M. (2001). "Wishing don't make it so" - Why we need a randomized clinical trial of high-intensity hemodialysis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 12(12), 2850-2853.
  
• Determinants of physical performance in ambulatory patients on hemodialysis Johansen, K. L., Chertow, G. M., Da Silva, M., Carey, S., & Painter, P. (2001). Determinants of physical performance in ambulatory patients on hemodialysis. KIDNEY INTERNATIONAL, 60(4), 1586-1591.
  
• Correlates of acute renal failure in patients receiving parenteral amphotericin B Bates, D. W., Su, L., Yu, D. T., Chertow, G. M., Seger, D. L., & Platt, R. (2001). Correlates of acute renal failure in patients receiving parenteral amphotericin B. KIDNEY INTERNATIONAL, 60(4), 1452-1459.
  
• Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients Kaysen, G. A., Chertow, G. M., Adhikarla, R., Young, B., Ronco, C., & Levin, N. W. (2001). Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients. KIDNEY INTERNATIONAL, 60(1), 333-340.
  
• Cardiac arrest and sudden death in dialysis units Karnik, J. A., Young, B. S., Lew, N. L., Herget, M., Dubinsky, C., & Chertow, G. M. (2001). Cardiac arrest and sudden death in dialysis units. KIDNEY INTERNATIONAL, 60(1), 350-357.
  
• Suspected iron dextran-related adverse drug events in hemodialysis patients Fletes, R., Lazarus, J. M., Gage, J., & Chertow, G. M. (2001). Suspected iron dextran-related adverse drug events in hemodialysis patients. AMERICAN JOURNAL OF KIDNEY DISEASES, 37(4), 743-749.
  
• Mortality and costs of acute renal failure associated with amphotericin B therapy Bates, D. W., Su, L., Yu, D. T., Chertow, G. M., Seger, D. L., & Platt, R. (2001). Mortality and costs of acute renal failure associated with amphotericin B therapy. CLINICAL INFECTIOUS DISEASES, 32(5), 686-693.
  
• beta(2)-microglobulin modified with advanced glycation end products delays monocyte apoptosis Hou, F. F., Miyata, T., Boyce, J., Yuan, Q., Chertow, G. M., & Owen, W. F. (2001). beta(2)-microglobulin modified with advanced glycation end products delays monocyte apoptosis. KIDNEY INTERNATIONAL, 59(3), 990-1002.
  
• Validation of questionnaires to estimate physical activity and functioning in end-stage renal disease Johansen, K. L., Painter, P., Kent-Braun, J. A., Ng, A. V., Carey, S., & Chertow, G. M. (2001). Validation of questionnaires to estimate physical activity and functioning in end-stage renal disease. KIDNEY INTERNATIONAL, 59(3), 1121-1127.
  
• Gridlock on the road to kidney transplantation Chertow, G. M., & Zenios, S. A. (2001). Gridlock on the road to kidney transplantation. AMERICAN JOURNAL OF KIDNEY DISEASES, 37(2), 435-437.
  
• Mechanisms underlying renoprotection during renin-angiotensin system blockade Taal, M. W., Chertow, G. M., Rennke, H. G., Gurnani, A., Jiang, T., & Mackenzie, H. S. (2001). Mechanisms underlying renoprotection during renin-angiotensin system blockade. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 280(2), F343-F355.
  
• Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients Chertow, G. M., Ackert, K., Lew, N. L., Lazarus, J. M., & Lowrie, E. G. (2000). Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients. KIDNEY INTERNATIONAL, 58(6), 2512-2517.
  
• Hyperparathyroidism and dialysis vintage Chertow, G. M., Plone, M., DILLON, M. A., Burke, S. K., & Slatopolsky, E. (2000). Hyperparathyroidism and dialysis vintage. CLINICAL NEPHROLOGY, 54(4), 295-300.
  
• Atrial natriuretic factor in oliguric acute renal failure Lewis, J., Salem, M. M., Chertow, G. M., Weisberg, L. S., McGrew, F., & Allgren, R. L. (2000). Atrial natriuretic factor in oliguric acute renal failure. AMERICAN JOURNAL OF KIDNEY DISEASES, 36(4), 767-774.
  
• Crystalloids versus colloids for resuscitation in shock Waikar, S. S., & Chertow, G. M. (2000). Crystalloids versus colloids for resuscitation in shock. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 9(5), 501-504.
  
• Chronic renal confusion: Insufficiency, failure, dysfunction, or disease Hsu, C., & Chertow, G. M. (2000). Chronic renal confusion: Insufficiency, failure, dysfunction, or disease. AMERICAN JOURNAL OF KIDNEY DISEASES, 36(2), 415-418.
  
• Dynamic allocation of kidneys to candidates on the transplant waiting list Zenios, S. Aa., Chertow, G. M., & Wein, L. M. (2000). Dynamic allocation of kidneys to candidates on the transplant waiting list. OPERATIONS RESEARCH, 48(4), 549-569.
  
• Sevelamer with and without calcium and vitamin D: observations from a long-term open-label clinical trial. Chertow, G. M., DILLON, M. A., Amin, N., & Burke, S. K. (2000). Sevelamer with and without calcium and vitamin D: observations from a long-term open-label clinical trial. Journal of renal nutrition , 10(3), 125-132.
  
• Ochrobactrum anthropi bacteremia in a patient on hemodialysis Chertow, G. M. (2000). Ochrobactrum anthropi bacteremia in a patient on hemodialysis. AMERICAN JOURNAL OF KIDNEY DISEASES, 35(6).
  
• Predicting acute renal failure after coronary bypass surgery: Cross-validation of two risk-stratification algorithms Fortescue, E. B., Bates, D. W., & Chertow, G. M. (2000). Predicting acute renal failure after coronary bypass surgery: Cross-validation of two risk-stratification algorithms. KIDNEY INTERNATIONAL, 57(6), 2594-2602.
  
• Physical activity levels in patients on hemodialysis and healthy sedentary controls Johansen, K. L., Chertow, G. M., Ng, A. V., Mulligan, K., Carey, S., & Kent-Braun, J. A. (2000). Physical activity levels in patients on hemodialysis and healthy sedentary controls. KIDNEY INTERNATIONAL, 57(6), 2564-2570.
  
• Leveling the "paying" field in end-stage renal disease Chertow, G. M. (2000). Leveling the "paying" field in end-stage renal disease. AMERICAN JOURNAL OF MEDICINE, 108(8), 666-668.
  
• Survival after acute myocardial infarction in patients with end-stage renal disease: Results from the Cooperative Cardiovascular Project Chertow, G. M., Normand, S. Lt., Silva, L. R., & McNeil, B. J. (2000). Survival after acute myocardial infarction in patients with end-stage renal disease: Results from the Cooperative Cardiovascular Project. AMERICAN JOURNAL OF KIDNEY DISEASES, 35(6), 1044-1051.
  
• Issues in renal nutrition for persons from the former Soviet Union. Gorodetskaya, I., Matel, J., & Chertow, G. M. (2000). Issues in renal nutrition for persons from the former Soviet Union. Journal of renal nutrition , 10(2), 98-102.
  
• Acute renal failure with interstitial nephritis in a patient with AIDS Mouratoff, J. G., Tokumoto, J., Olson, J. L., & Chertow, G. M. (2000). Acute renal failure with interstitial nephritis in a patient with AIDS. AMERICAN JOURNAL OF KIDNEY DISEASES, 35(3), 557-561.
  
• Vintage, nutritional status, and survival in hemodialysis patients Chertow, G. M., Johansen, K. L., Lew, N., Lazarus, J. M., & Lowrie, E. G. (2000). Vintage, nutritional status, and survival in hemodialysis patients. KIDNEY INTERNATIONAL, 57(3), 1176-1181.
  
• Reply from the authors Chertow, G. M. (2000). Reply from the authors. Kidney international, 58(3), 1358-9.
  
• Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients Chertow, G. M., Burke, S. K., Dillon, M. A., & Slatopolsky, E. (2000). Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 15(4), 559.
  
• Renal nutrition in the new millennium. Chertow, G. M. (2000). Renal nutrition in the new millennium. Journal of renal nutrition , 10(1), 1-?.
  
• Exploring the reverse J-shaped curve between urea reduction ratio and mortality Chertow, G. M., Owen, W. F., Lazarus, J. M., Lew, N. L., & Lowrie, E. G. (1999). Exploring the reverse J-shaped curve between urea reduction ratio and mortality. KIDNEY INTERNATIONAL, 56(5), 1872-1878.
  
• Bioelectrical impedance methods in clinical research: A follow-up to the NIH technology assessment conference Ellis, K. J., Bell, S. J., Chertow, G. M., Chumlea, W. C., Knox, T. A., & Schoeller, D. A. (1999). Bioelectrical impedance methods in clinical research: A follow-up to the NIH technology assessment conference. NUTRITION, 15(11-12), 874-880.
  
• The urea {clearance x dialysis time} product (Kt) as an outcome-based measure of hemodialysis dose Lowrie, E. G., Chertow, G. M., Lew, N. L., Lazarus, J. M., & Owen, W. F. (1999). The urea {clearance x dialysis time} product (Kt) as an outcome-based measure of hemodialysis dose. KIDNEY INTERNATIONAL, 56(2), 729-737.
  
• Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure Weinfeld, M. S., Chertow, G. M., & Stevenson, L. W. (1999). Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. AMERICAN HEART JOURNAL, 138(2), 285-290.
  
• Estimates of body composition as intermediate outcome variables: are DEXA and BIA ready for prime time? Chertow, G. M. (1999). Estimates of body composition as intermediate outcome variables: are DEXA and BIA ready for prime time?. Journal of renal nutrition , 9(3), 138-141.
  
• Evidence-based organ allocation Zenios, S. A., Wein, L. M., & Chertow, G. M. (1999). Evidence-based organ allocation. AMERICAN JOURNAL OF MEDICINE, 107(1), 52-61.
  
• Metabolic and monetary casts of avoidable parenteral nutrition use Trujillo, E. B., Young, L. S., Chertow, G. M., Randall, S., Clemons, T., & Robinson, M. K. (1999). Metabolic and monetary casts of avoidable parenteral nutrition use. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 23(2), 109-113.
  
• Modality-specific nutrition support in ESRD: Weighing the evidence Chertow, G. M. (1999). Modality-specific nutrition support in ESRD: Weighing the evidence. AMERICAN JOURNAL OF KIDNEY DISEASES, 33(1), 193-197.
  
• A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium - Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients Chertow, G. M., Dillon, M., Burke, S. K., Steg, M., Bleyer, A. J., & Slatopolsky, E. (1999). A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium - Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients. CLINICAL NEPHROLOGY, 51(1), 18-26.
  
• Dose of hemodialysis and survival - Differences by race and sex Owen, W. F., Chertow, G. M., Lazarus, J. M., & Lowrie, E. G. (1998). Dose of hemodialysis and survival - Differences by race and sex. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 280(20), 1764-1768.
  
• Clearance of Pneumocystis carinii cysts in acute P carinii pneumonia - Assessment by serial sputum induction O'Donnell, W. J., Pieciak, W., Chertow, G. M., Sanabria, J., & Lahive, K. C. (1998). Clearance of Pneumocystis carinii cysts in acute P carinii pneumonia - Assessment by serial sputum induction. CHEST, 114(5), 1264-1268.
  
• Effects of estrogen replacement therapy on the lipoprotein profile in postmenopausal women with ESRD Ginsburg, E. S., Walsh, B., Greenberg, L., Price, D., Chertow, G. M., & Owen, W. F. (1998). Effects of estrogen replacement therapy on the lipoprotein profile in postmenopausal women with ESRD. KIDNEY INTERNATIONAL, 54(4), 1344-1350.
  
• Cancer screening and detection in patients with end-stage renal disease Gornik, H. L., Lazarus, J. M., & Chertow, G. M. (1998). Cancer screening and detection in patients with end-stage renal disease. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 21(9), 495-500.
  
• Haemobilia mimicking acute cholecystitis following percutaneous renal biopsy Lee, M. C., Jacobs, D. O., & Chertow, G. M. (1998). Haemobilia mimicking acute cholecystitis following percutaneous renal biopsy. NEPHROLOGY DIALYSIS TRANSPLANTATION, 13(8), 2118-2120.
  
• beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts Owen, W. F., Hou, F. F., Stuart, R. O., Kay, J., Boyce, J., & Schimidt, A. M. (1998). beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts. KIDNEY INTERNATIONAL, 53(5), 1365-1373.
  
• Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis Chertow, G. M., Lazarus, J. M., Paganini, E. P., Allgren, R. L., Lafayette, R. A., & Sayegh, M. H. (1998). Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 9(4), 692-698.
  
• Independent association between acute renal failure and mortality following cardiac surgery Chertow, G. M., Levy, E. M., Hammermeister, K. E., Grover, F., & Daley, J. (1998). Independent association between acute renal failure and mortality following cardiac surgery. AMERICAN JOURNAL OF MEDICINE, 104(4), 343-348.
  
• Olecranon bursitis caused by infection with Candida lusitaniae Behar, S. M., & Chertow, G. H. (1998). Olecranon bursitis caused by infection with Candida lusitaniae. JOURNAL OF RHEUMATOLOGY, 25(3), 598-600.
  
• Dialysis: Cost-effective "SUPPORT" for patients with acute renal failure Chertow, G. M. (1998). Dialysis: Cost-effective "SUPPORT" for patients with acute renal failure. AMERICAN JOURNAL OF KIDNEY DISEASES, 31(3), 545-548.
  
• Aminoguanidine inhibits advanced glycation end products formation on beta 2-microglobulin Hou, F. F., Boyce, J., Chertow, G. M., Kay, J., & Owen, W. F. (1998). Aminoguanidine inhibits advanced glycation end products formation on beta 2-microglobulin. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 9(2), 277-283.
  
• Allocation of kidneys to patients on the transplant waiting list: a simulation-based policy model Zenios, S. A., Chertow, G. M., & Wein, L. M. (1998). Allocation of kidneys to patients on the transplant waiting list: a simulation-based policy model. ORGAN ALLOCATION, 30, 133-133.
  
• Bioimpedance norms for the hemodialysis population Chertow, G. M., Lazarus, J. M., Lew, N. L., Ma, L. H., & Lowrie, E. G. (1997). Bioimpedance norms for the hemodialysis population. KIDNEY INTERNATIONAL, 52(6), 1617-1621.
  
• Antigen-independent determinants of graft survival in living-related kidney transplantation Chertow, G. M., BRENNER, B. M., Mori, M., Mackenzie, H. S., & Milford, E. L. (1997). Antigen-independent determinants of graft survival in living-related kidney transplantation. KIDNEY INTERNATIONAL, S84-S86.
  
• On the design and analysis of multicenter trials in acute renal failure Chertow, G. M. (1997). On the design and analysis of multicenter trials in acute renal failure. AMERICAN JOURNAL OF KIDNEY DISEASES, 30(5), S96-S101.
  
• Renal vasculitis with HIV seropositivity: Potential manifestation of cytomegalovirus infection Chertow, G. M., Rennke, H. G., Curhan, G. C., & Brady, H. R. (1997). Renal vasculitis with HIV seropositivity: Potential manifestation of cytomegalovirus infection. AMERICAN JOURNAL OF KIDNEY DISEASES, 30(3), 428-432.
  
• Allocation of kidneys to patients on the transplant waiting list. Assessing the trade-off between equity and efficiency. Zenios, S. A., Chertow, G. M., & Wein, L. M. (1997). Allocation of kidneys to patients on the transplant waiting list. Assessing the trade-off between equity and efficiency. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 8, A3291-A3291.
  
• The rise and fall of atrial natriuretic peptide for acute renal failure Brenner, R. M., & Chertow, G. M. (1997). The rise and fall of atrial natriuretic peptide for acute renal failure. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 6(5), 474-476.
  
• Nephrology Chertow, G. M. (1997). Nephrology. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 277(23), 1872-1873.
  
• Interaction between beta 2-microglobulin and advanced glycation end products in the development of dialysis related amyloidosis Hou, F. F., Chertow, G. M., Kay, J., Boyce, J., Lazarus, J. M., & Owen, W. F. (1997). Interaction between beta 2-microglobulin and advanced glycation end products in the development of dialysis related amyloidosis. KIDNEY INTERNATIONAL, 51(5), 1514-1519.
  
• Development of a population-specific regression equation to estimate total body water in hemodialysis patients Chertow, G. M., Lazarus, J. M., Lew, N. L., Ma, L. H., & Lowrie, E. G. (1997). Development of a population-specific regression equation to estimate total body water in hemodialysis patients. KIDNEY INTERNATIONAL, 51(5), 1578-1582.
  
• A practical approach to acute renal failure Mindell, J. A., & Chertow, G. M. (1997). A practical approach to acute renal failure. MEDICAL CLINICS OF NORTH AMERICA, 81(3), 731-?.
  
• Preoperative renal risk stratification Chertow, G. M., Lazarus, J. M., Christiansen, C. L., Cook, E. F., Hammermeister, K. E., & Daley, J. (1997). Preoperative renal risk stratification. CIRCULATION, 95(4), 878-884.
  
• Poorer graft survival in African-American transplant recipients cannot be explained by HLA mismatching. Chertow, G. M., & Milford, E. L. (1997). Poorer graft survival in African-American transplant recipients cannot be explained by HLA mismatching. Advances in renal replacement therapy, 4(1), 40-45.
  
• Poly[allylamine hydrochloride] (RenaGel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure Chertow, G. M., Burke, S. K., Lazarus, J. M., Stenzel, K. H., Wombolt, D., & Slatopolsky, E. (1997). Poly[allylamine hydrochloride] (RenaGel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure. AMERICAN JOURNAL OF KIDNEY DISEASES, 29(1), 66-71.
  
• Antigen-independent determinants of cadaveric kidney transplant failure Chertow, G. M., Milford, E. L., Mackenzie, H. S., & BRENNER, B. M. (1996). Antigen-independent determinants of cadaveric kidney transplant failure. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 276(21), 1732-1736.
  
• Intensity of dialysis in established acute renal failure Chertow, G. M., & Lazarus, J. M. (1996). Intensity of dialysis in established acute renal failure. SEMINARS IN DIALYSIS, 9(6), 476-480.
  
• Grafts vs fistulas for hemodialysis patients - Equal access for all? Chertow, G. M. (1996). Grafts vs fistulas for hemodialysis patients - Equal access for all?. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 276(16), 1343-1344.
  
• Fanconi's syndrome and tubulointerstitial nephritis in association with L-lysine ingestion Lo, J. C., Chertow, G. M., Rennke, H., & Seifter, J. L. (1996). Fanconi's syndrome and tubulointerstitial nephritis in association with L-lysine ingestion. AMERICAN JOURNAL OF KIDNEY DISEASES, 28(4), 614-617.
  
• Birth weight and adult hypertension and obesity in women Curhan, G. C., Chertow, G. M., Willett, W. C., Spiegelman, D., Colditz, G. A., & Stampfer, M. J. (1996). Birth weight and adult hypertension and obesity in women. CIRCULATION, 94(6), 1310-1315.
  
• Restless legs syndrome in end-stage renal disease Winkelman, J. W., Chertow, G. M., & Lazarus, J. M. (1996). Restless legs syndrome in end-stage renal disease. AMERICAN JOURNAL OF KIDNEY DISEASES, 28(3), 372-378.
  
• Trimethoprim-sulfamethoxazole and hypouricemia Chertow, G. M., Seifter, J. L., Christiansen, C. L., & ODONNELL, W. J. (1996). Trimethoprim-sulfamethoxazole and hypouricemia. CLINICAL NEPHROLOGY, 46(3), 193-198.
  
• Performance characteristics of a dialysis-related amyloidosis questionnaire Chertow, G. M., TRIMBUR, T., Karlson, E. W., Lazarus, J. M., & Kay, J. (1996). Performance characteristics of a dialysis-related amyloidosis questionnaire. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 7(8), 1235-1240.
  
• ''Renal-dose'' dopamine for the treatment of acute renal failure: Scientific rationale, experimental studies and clinical trials Denton, M. D., Chertow, G. M., & Brady, H. R. (1996). ''Renal-dose'' dopamine for the treatment of acute renal failure: Scientific rationale, experimental studies and clinical trials. KIDNEY INTERNATIONAL, 50(1), 4-14.
  
• Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Chertow, G. M., Sayegh, M. H., Allgren, R. L., & Lazarus, J. M. (1996). Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure?. AMERICAN JOURNAL OF MEDICINE, 101(1), 49-53.
  
• Cost-effectiveness of cancer screening in end-stage renal disease Chertow, G. M., Paltiel, A. D., Owen, W. F., & Lazarus, J. M. (1996). Cost-effectiveness of cancer screening in end-stage renal disease. ARCHIVES OF INTERNAL MEDICINE, 156(12), 1345-1350.
  
• Nutrition and the dialysis prescription Chertow, G. M., Bullard, A., & Lazarus, J. M. (1996). Nutrition and the dialysis prescription. AMERICAN JOURNAL OF NEPHROLOGY, 16(1), 79-89.
  
• Non-immunologic predictors of chronic renal allograft failure: data from the United Network of Organ Sharing. Chertow, G. M., BRENNER, B. M., Mackenzie, H. S., & Milford, E. L. (1995). Non-immunologic predictors of chronic renal allograft failure: data from the United Network of Organ Sharing. Kidney international. Supplement, 52, S48-51.
  
• NONIMMUNOLOGICAL PREDICTORS OF CHRONIC RENAL-ALLOGRAFT FAILURE - DATA FROM THE UNITED-NETWORK-OF-ORGAN-SHARING Chertow, G. M., BRENNER, B. M., Mackenzie, H. S., & Milford, E. L. (1995). NONIMMUNOLOGICAL PREDICTORS OF CHRONIC RENAL-ALLOGRAFT FAILURE - DATA FROM THE UNITED-NETWORK-OF-ORGAN-SHARING. KIDNEY INTERNATIONAL, 48, S48-S51.
  
• MULTIFREQUENCY BIOELECTRICAL-IMPEDANCE ESTIMATES THE DISTRIBUTION OF BODY-WATER Cha, K. C., Chertow, G. M., Gonzalez, J., Lazarus, J. M., & Wilmore, D. W. (1995). MULTIFREQUENCY BIOELECTRICAL-IMPEDANCE ESTIMATES THE DISTRIBUTION OF BODY-WATER. JOURNAL OF APPLIED PHYSIOLOGY, 79(4), 1316-1319.
  
• PROGNOSTIC STRATIFICATION IN CRITICALLY ILL PATIENTS WITH ACUTE-RENAL-FAILURE REQUIRING DIALYSIS Chertow, G. M., Christiansen, C. L., Cleary, P. D., Munro, C., & Lazarus, J. M. (1995). PROGNOSTIC STRATIFICATION IN CRITICALLY ILL PATIENTS WITH ACUTE-RENAL-FAILURE REQUIRING DIALYSIS. ARCHIVES OF INTERNAL MEDICINE, 155(14), 1505-1511.
  
• NUTRITIONAL ASSESSMENT WITH BIOELECTRICAL-IMPEDANCE ANALYSIS IN MAINTENANCE HEMODIALYSIS-PATIENTS Chertow, G. M., Lowrie, E. G., Wilmore, D. W., Gonzalez, J., Lew, N. L., & Lazarus, J. M. (1995). NUTRITIONAL ASSESSMENT WITH BIOELECTRICAL-IMPEDANCE ANALYSIS IN MAINTENANCE HEMODIALYSIS-PATIENTS. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 6(1), 75-81.
  
• THE ASSOCIATION OF INTRADIALYTIC PARENTERAL-NUTRITION ADMINISTRATION WITH SURVIVAL IN HEMODIALYSIS-PATIENTS Chertow, G. M., Ling, J., Lew, N. L., Lazarus, J. M., & Lowrie, E. G. (1994). THE ASSOCIATION OF INTRADIALYTIC PARENTERAL-NUTRITION ADMINISTRATION WITH SURVIVAL IN HEMODIALYSIS-PATIENTS. AMERICAN JOURNAL OF KIDNEY DISEASES, 24(6), 912-920.
  
• POTENTIAL IDENTIFIABILITY AND PREVENTABILITY OF ADVERSE EVENTS USING INFORMATION-SYSTEMS Bates, D. W., ONEIL, A. C., Boyle, D., Teich, J., Chertow, G. M., & Brennan, T. A. (1994). POTENTIAL IDENTIFIABILITY AND PREVENTABILITY OF ADVERSE EVENTS USING INFORMATION-SYSTEMS. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 1(5), 404-411.
  
• CONGENITAL OLIGONEPHROPATHY AND THE ETIOLOGY OF ADULT HYPERTENSION AND PROGRESSIVE RENAL INJURY BRENNER, B. M., & Chertow, G. M. (1994). CONGENITAL OLIGONEPHROPATHY AND THE ETIOLOGY OF ADULT HYPERTENSION AND PROGRESSIVE RENAL INJURY. AMERICAN JOURNAL OF KIDNEY DISEASES, 23(2), 171-175.
  
• Congenital oligonephropathy: an inborn cause of adult hypertension and progressive renal injury? BRENNER, B. M., & Chertow, G. M. (1993). Congenital oligonephropathy: an inborn cause of adult hypertension and progressive renal injury?. Current opinion in nephrology and hypertension, 2(5), 691-695.